<SEC-DOCUMENT>0001213900-25-085190.txt : 20250908
<SEC-HEADER>0001213900-25-085190.hdr.sgml : 20250908
<ACCEPTANCE-DATETIME>20250905180929
ACCESSION NUMBER:		0001213900-25-085190
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20250902
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250908
DATE AS OF CHANGE:		20250905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Next Technology Holding Inc.
		CENTRAL INDEX KEY:			0001784970
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			WY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41450
		FILM NUMBER:		251297726

	BUSINESS ADDRESS:	
		STREET 1:		RM 519, 05/F, BLOCK T3, QIANHAI PREMIER
		STREET 2:		FINANCE CENTRE UNIT 2, GUIWAN AREA
		CITY:			NANSHAN DISTRICT, SHENZHEN
		STATE:			F4
		ZIP:			518000
		BUSINESS PHONE:		852 96369080

	MAIL ADDRESS:	
		STREET 1:		RM 519, 05/F, BLOCK T3, QIANHAI PREMIER
		STREET 2:		FINANCE CENTRE UNIT 2, GUIWAN AREA
		CITY:			NANSHAN DISTRICT, SHENZHEN
		STATE:			F4
		ZIP:			518000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WETRADE GROUP INC.
		DATE OF NAME CHANGE:	20240402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Next Technology Holding Inc.
		DATE OF NAME CHANGE:	20240401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WeTrade Group Inc.
		DATE OF NAME CHANGE:	20190808
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0256179-8k_nexttech.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:NXTT="http://nxtttech.com/20250902">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_NXTT_nxtttech.com_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250902_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001784970 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001784970</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nxtt-20250902.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001784970</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-02</xbrli:startDate>
        <xbrli:endDate>2025-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20250902__20250902_zzKYFlMrNTpe"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE<br/>
SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (date of earliest event reported):
<b><span id="xdx_908_edei--DocumentPeriodEndDate_c20250902__20250902_znTKAswjJqxj"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 2, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20250902__20250902_zS38mvaDcud3"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000011" name="dei:EntityRegistrantName">NEXT TECHNOLOGY HOLDING INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: none">(Exact name of Registrant as specified in its charter)</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250902__20250902_zrMYWQE94NSl"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Wyoming</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><b><span id="xdx_905_edei--EntityFileNumber_c20250902__20250902_zEBvYTb4Qylc"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000013" name="dei:EntityFileNumber">001-41450</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250902__20250902_zqxr9WKchJOj"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">84-4948289</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="text-align: center"><b>(State or other jurisdiction<br/>
</b> <b>of incorporation)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><b>(Commission File No.)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><b>(IRS Employer</b> <b><br/>
Identification No.)</b></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20250902__20250902_zJDTwm1Zx7Q8"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000015" name="dei:EntityAddressAddressLine1">Room 519, 05/F Block T3</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressAddressLine2_c20250902__20250902_zbeJxpw41LDf"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000016" name="dei:EntityAddressAddressLine2">Qianhai Premier Finance Centre Unit 2</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressAddressLine3_c20250902__20250902_zjJ29y7ArPkl"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000017" name="dei:EntityAddressAddressLine3">Guiwan
Area, Nanshan District</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressCityOrTown_c20250902__20250902_zRfoY6DBqOdf"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000018" name="dei:EntityAddressCityOrTown">Shenzhen</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCountry_c20250902__20250902_z3Zf1hBiC6Bi"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:countrynameen" id="Fact000019" name="dei:EntityAddressCountry">China</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20250902__20250902_z04Hd0Hr8Lqe"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000020" name="dei:EntityAddressPostalZipCode">518000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--CityAreaCode_c20250902__20250902_zhdczXg6Dge"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000021" name="dei:CityAreaCode">+44</ix:nonNumeric></span>-<span id="xdx_90F_edei--LocalPhoneNumber_c20250902__20250902_zC790gugzhDg"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000022" name="dei:LocalPhoneNumber">7421477289</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Wyoming Registered Agent</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">1621 Central Ave Cheyenne, Wyoming 82001</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--WrittenCommunications_c20250902__20250902_z0CA6O1BFHw5"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SolicitingMaterial_c20250902__20250902_znlEpf9qkFG8"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250902__20250902_zAxzDSBvRhCf"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250902__20250902_zSobLqTqxvSh"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Each Exchange on Which Registered</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250902__20250902_zCO3XHjwuHNa"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000027" name="dei:Security12bTitle">Common Stock, no par value per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20250902__20250902_z7rZGtumkUB8"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000028" name="dei:TradingSymbol">NXTT</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SecurityExchangeName_c20250902__20250902_zJwksHiPsNk"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;203.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;204.12b-2 of this chapter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250902__20250902_zQl2yQqwhEZ5"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleantrue" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span id="xdx_90F_edei--EntityExTransitionPeriod_c20250902__20250902_z76m7sLB6ldg"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 2, 2025, Next
Technology Holding Inc., a Wyoming corporation (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase
Agreement&#8221;) with certain institutional investor named thereto (the &#8220;Purchaser&#8221;), pursuant to which the Company agreed
to issue and sell, in a registered direct offering (the &#8220;Offering&#8221;): (i) 25,313,256 shares of common stock (the &#8220;Common
Stock&#8221;) of the Company, no par value per share (the &#8220;Shares&#8221;), at a purchase price of $0.15 per share; and (ii) pre-funded
warrants to purchase up to 34,686,744 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;) at a purchase price of $0.149 per
Pre-Funded Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Offering closed on September
3, 2025. The Company received approximately $9 million in gross proceeds from the Offering, before deducting placement agent fees and
estimated offering expenses. The Company intends to use the net proceeds from the Offering for working capital purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Pre-Funded Warrants were
sold to the Purchaser, whose purchase of the Shares in the Offering would otherwise have resulted in the Purchaser, together with its
affiliates and certain related parties, beneficially owning more than 9.99% of the outstanding share capital of the Company following
the consummation of the Offering. Each Pre-Funded Warrant represents the right to purchase one share of Common Stock at an exercise price
of $0.001 per share. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until the Pre-Funded Warrants
are exercised in full (subject to the beneficial ownership limitation described above). As of the date of this report, the Purchaser has
exercised the Pre-Funded Warrants to purchase 34,686,744 shares of Common Stock, and the Company has issued to the Purchaser such 34,686,744
shares of Common Stock in accordance with the terms of the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the
Company, other obligations of the parties, and termination provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company agreed
that for a period of sixty (60) days from the closing date of the Offering, it will not: (i) issue, enter into any agreement to issue
or announce the issuance or proposed issuance of any shares of Common Stock or equivalent securities; or (ii) file any registration statement
or amendment or supplement thereto (other than the Prospectus Supplement, the filing of any amendment or supplement to an existing registration
statement for an &#8220;at the market&#8221; offering with the Placement Agent as sales agent, or on Form S-8 or in connection with any
employee benefit plan). In addition, the Company agreed that it will not conduct any sales of Common Stock or equivalent securities involving
a variable rate transaction (as defined in the Purchase Agreement) for a period of sixty (60) days from the closing date of the Offering,
<span style="background-color: white">subject to certain exceptions as described in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares, the Pre-Funded
Warrants and the shares of Common Stock underlying the Pre-funded Warrants (together with the Shares and the Pre-Funded Warrants, the
&#8220;Securities&#8221;) were offered by the Company pursuant to a registration statement on <span style="text-decoration: none">Form S-3</span>, as amended (File No. 333-267362)
(the &#8220;Registration Statement&#8221;), previously filed and declared effective by the Securities and Exchange Commission (the &#8220;Commission&#8221;)
on September 16, 2022, the base prospectus filed as part of the Registration Statement, and the prospectus supplement dated September
2, 2025 (the &#8220;Prospectus Supplement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 2, 2025, the
Company entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;) with <span style="background-color: white">Univest
Securities, LLC</span> (&#8220;<span style="background-color: white">Univest</span>&#8221; or the &#8220;Placement Agent&#8221;), pursuant
to which the Company engaged <span style="background-color: white">Univest</span> as the exclusive placement agent in connection with
the Offering. The Placement Agent agreed to use its reasonable best efforts to arrange for the sale of the Shares and the Pre-Funded Warrants.
In addition, under the Placement Agency Agreement the Company agreed to pay the Placement Agent a placement agent fee in cash equal to
seven percent (7%) of the aggregate gross proceeds raised from the sale. The Company also agreed to reimburse the Placement Agent at closing
for legal and other expenses incurred by them in connection with the Offering in an amount not to exceed $150,000, and a non-accountable
expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Placement Agency Agreement
contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations
of the Company and the Placement Agent, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), other obligations of the parties and termination provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summaries of
the Placement Agency Agreement, the Purchase Agreement and the Pre-Funded Warrants do not purport to be complete and are subject to, and
qualified in their entirety by, such documents filed as Exhibits 1.1, 10.1 and 4.1, respectively, hereto and incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report on Form
8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any
offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.01. Notice of Delisting of Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As previously disclosed in
the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 28, 2025, on August 25, 2025, the Company received a letter
from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) indicating Nasdaq&#8217;s view that the
Company no longer has an operating business and is a &#8220;public shell&#8221; under Nasdaq Listing Rule 5101 and, as a result, unless
the Company timely requests a hearing before a Hearings Panel (the &#8220;Panel&#8221;), it would be subject to delisting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company disagrees with
Nasdaq&#8217;s view regarding the Company&#8217;s status as a &#8220;public shell&#8221; and has appealed Nasdaq&#8217;s determination
by submitting a hearing request form on September 2, 2025. On September 3, 2025, the Company received confirmation from Nasdaq that an
oral hearing before the Panel has been granted and scheduled for October 7, 2025, at 11:00 a.m. Eastern Time. The hearing request automatically
stays any suspension or delisting action pending the hearing and the expiration of any additional extension period that may be granted
by the Panel pursuant to the hearing. There can be no assurance that the Company&#8217;s appeal of the delisting determination will be
successful, or that, if successful, the Company will be able to maintain compliance with all applicable listing criteria.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 2, 2025, the
Company issued a press release related to the Offering entitled &#8220;Next Technology Holding Inc. Announces $9 Million Registered Direct
Offering&#8221;, which press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this
Item 8.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities
of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except
as expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This report is incorporated
by reference into the registration statements on <span style="text-decoration: none">Form S-8</span> (File No. 333-288503) and on <span style="text-decoration: none">Form S-3</span> (File No. 333-267362) of
the Company, filed with the Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded
by documents or reports subsequently filed or furnished.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Forward Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report on Form 8-K contains &#8220;forward-looking
statements&#8221; within the meaning of federal and state securities laws. Such statements can be identified by words such as &#8220;will
likely result,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221;
&#8220;plan,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may&#8221; or words
of similar meaning and include, but are not limited to, statements regarding our future business and financial performance and prospects,
including our expectations regarding the transactions described in this Current Report on Form 8-K. Such forward-looking statements are
based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive
uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing
of events may differ materially from the results included in such forward-looking statements. Investors are cautioned not to place undue
reliance on the forward-looking statements in this Current Report on Form 8-K, which information set forth herein speaks only as of the
date hereof. The Company does not undertake, and it expressly disclaims, any intention or obligation to update any forward-looking statements
made in this Current Report on Form 8-K, whether as a result of new information, future events or otherwise, except as required by law.
A list and description of risks, uncertainties and other factors that could cause or contribute to differences in the Company&#8217;s
results can be found in its filings with the SEC, including its most recent Annual Report on Form 10-K and subsequent filings. The Company
qualifies all of its forward-looking statements by these cautionary statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit Index</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b> </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex1-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency Agreement, dated September 2, 2025, by and between the Company and Univest Securities, LLC</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex4-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of the Pre-Funded Warrants</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex5-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of McLaughlin &amp; Stern, LLP&#160;</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex5-2_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Long Reimer Winegar LLP </span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex10-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Form of Securities Purchase Agreement, dated September 2, 2025, by and among the Company and the purchaser thereto</span></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex5-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Long Reimer Winegar LLP (included in Exhibit 5.1)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex5-2_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of McLaughlin &amp; Stern, LLP&#160; (included in Exhibit 5.2)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea025617901ex99-1_nexttech.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Next Technology Holding Inc.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Wei Hong Liu</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weihong LIU</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: September 5, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbObqLg7HTrEKTJEvC0uk+LWjLT+PZJvad0QQyAk53w5QgxERitdI8NpUeRwwKatlUMosEJGc0bvSNebBPws8KKtY2Vct/7AlDyDnpmEkfL3znnXFssE5Gwox8N4DHKUxFOYb0Xw1VMylS7ROK1qUKaEPVPLGp3iV//hoJ5kqHl1SUdkq8kkEIWyl98QyyiGHd3Vg/hqIc9TEQy6CkTGdGu9a/l0aL4kLGtsfJzt6X8HH8XHSlI= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea025617901ex1-1_nexttech.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED SEPTEMBER 2, 2025, BY AND BETWEEN THE COMPANY AND UNIVEST SECURITIES, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 1.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PLACEMENT AGENCY AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">September 2, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Univest Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">75 Rockefeller Plaza, Suite 18C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">New York, NY, 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">This letter (the
&ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement by and between Univest Securities, LLC (&ldquo;<B>Univest</B>&rdquo; or
the &ldquo;<B>Placement Agent</B>&rdquo;) and Next Technology Holding Inc., f/k/a WeTrade Group Inc., a Wyoming corporation (the
&ldquo;<B>Company</B>&rdquo;), pursuant to which the Placement Agent shall serve as the placement agent for the Company, on a
&ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed placements (the &ldquo;<B>Placements</B>&rdquo;) via a
registered direct offering of common stock, no par value (&ldquo;<B>Common Stock</B>&rdquo;), of the Company and the Pre-Funded
Warrants to purchase Common Stock (together with the Common Stock, the &ldquo;<B>Securities</B>&rdquo;). The terms of the Placements
and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo; and
collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein shall be deemed to mean that the Placement Agent would have
the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the
Placements. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the
Placements, including but not limited to the Purchase Agreement (as defined below), shall be collectively referred to herein as the
&ldquo;<B>Transaction Documents</B>.&rdquo; The date of the closing of the Placements shall be referred to herein as the
&ldquo;<B>Closing Date</B>.&rdquo; The Company expressly acknowledges and agrees that the obligations of the Placement Agent
hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by
the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof
or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. Following the prior
written consent of the Company, the Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on
its behalf in connection with the Placements. The sale of the Securities to any Purchaser will be evidenced by a securities purchase
agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between the Company and such Purchaser in a form mutually agreed upon by the
Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the
Purchase Agreement. Prior to the signing of any Purchase Agreement, executive officers of the Company will be available upon
reasonable notice and during normal business hours to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Notwithstanding anything
herein to the contrary, in the event that the Placement Agent determines that any of the terms provided for hereunder do not comply with
a Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) rule, including but not limited to FINRA Rule 5110, then the Company
shall agree to amend this Agreement in writing upon the request of the Placement Agent to comply with any such rules; provided that any
such amendments shall not provide for terms that are less favorable to the Company than the terms of this Agreement or terms are adverse
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">The Company hereby confirms its agreement
with the Placement Agent as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 1. Agreement to Act as Placement
Agent<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) On the basis of
the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions of this
Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company of the
Securities pursuant to the Company&rsquo;s registration statement on Form S-3 (File No. 333-267362) (the &ldquo;<B>Registration
Statement</B>&rdquo;) with the terms of such offering (the &ldquo;<B>Offering</B>&rdquo;) to be subject to market conditions and
negotiations between the Company, the Placement Agent and the prospective Purchasers. The Placement Agent will act on a best efforts
basis and the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any
portion thereof, in the prospective Offering. Under no circumstances will the Placement Agent or any of its Affiliates (as defined
below) be obligated to underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The
Placement Agent shall act solely as the Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to
bind the Company with respect to any prospective offer to purchase Securities and the Company shall have the sole right to accept
offers to purchase Securities and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof,
payment of the purchase price for, and delivery of, the Securities shall be made at one closing (the &ldquo;<B>Closing</B>&rdquo;
and the date on which the Closing occurs, the &ldquo;<B>Closing Date</B>&rdquo;). As compensation for services rendered, on the
Closing Date, the Company shall pay to the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a cash fee equal to seven percent (7%) of the aggregate gross proceeds received by the Company from the sale of the Securities
(the &ldquo;<B>Cash Fee</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a non-accountable expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the sale of the Securities;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">reimbursement of the Placement Agent&rsquo;s all reasonable
travel and other out-of-pocket expenses, including the reasonable fees, costs, and disbursements of its legal counsel, in an amount not
to exceed an aggregate of $150,000.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) The
term of the Placement Agent&rsquo;s exclusive engagement shall begin on the date hereof and continue until the earlier of (i) the Closing
Date (the &ldquo;<B>Exclusive Term</B>&rdquo;), and (ii) the date the Placement Agent or the Company terminates the engagement according
to the terms of the next sentence (such date, the &ldquo;<B>Termination Date</B>&rdquo; and the period of time during which this Agreement
remains in effect is referred to herein as the &ldquo;<B>Term</B>&rdquo;). The engagement may be terminated at any time by either party
hereto upon seven (7) days written notice to the other party, effective upon receipt of written notice to that effect by the other party.
Unless otherwise provided under this Agreement, the provisions concerning the Company&rsquo;s obligation to pay any fees actually earned
pursuant to <U>Section 1(a)</U> hereof and to pay or reimburse the Placement Agent for any expenses incurred in accordance with <U>Section
6</U> hereof, the Company&rsquo;s obligations contained in the indemnification provisions, and the provisions concerning indemnification
and contribution contained herein will survive any expiration or termination of this Agreement for any reason. All fees and expense payments
or reimbursements due to the Placement Agent shall be paid by the Company to the Placement Agent on or before the Termination Date (in
the event such fees and expenses are earned or owed as of the Termination Date). Furthermore, the Company agrees that during the Placement
Agent&rsquo;s engagement hereunder, all inquiries from prospective U.S. Purchasers with respect to the Offering will be referred to the
Placement Agent. Additionally, except as set forth hereunder or otherwise disclosed to the Placement Agent in writing, the Company represents,
warrants and covenants that no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any subsidiary
of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other third-party with
respect to the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The services provided by
the Placement Agent hereunder are solely for the benefit of the Company and are not intended to confer any rights upon any persons or
entities not a party hereto (including, without limitation, security holders, employees or creditors of the Company) as against the Placement
Agent or its directors, officers, agents and employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 2. Representations, Warranties and
Covenants of the Company</B>. The Company hereby represents and warrants to the Placement Agent that the following is true and correct
as of the date hereof, and will be true and correct as of the Closing Date, and covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) <U>Securities Law
Filings</U>. The Company has prepared and filed with the U.S. Securities and Exchange Commission (the
&ldquo;<B>Commission</B>&rdquo;) a registration statement on Form S-3 (File No. 333-267362) for the registration under the
Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), of the Securities, which registration statement became
effective on September 16, 2022. At the time of such filing, the Company met the requirements of Form S-3 under the Securities Act.
Such registration statement meets the requirements set forth in Rule 415(a)(1)(x) under the Securities Act and complies with said
Rule. The Company will file with the Commission pursuant to Rule 424(b) under the Securities Act, and the rules and regulations (the
&ldquo;<B>Rules and Regulations</B>&rdquo;) of the Commission promulgated thereunder, a supplement to the form of prospectus
included in such registration statement relating to the placement of the Public Securities and the plan of distribution thereof and
has advised the Placement Agent of all further information (financial and other) with respect to the Company required to be set
forth therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter
called the &ldquo;<B>Registration Statement</B>&rdquo;; such prospectus in the form in which it appears in the Registration
Statement is hereinafter called the &ldquo;<B>Base Prospectus</B>&rdquo;; and the supplemented form of prospectus, in the form in
which it will be filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as so supplemented) is hereinafter
called the &ldquo;<B>Prospectus Supplement</B>.&rdquo; Any reference in this Agreement to the Registration Statement, the Base
Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein (the
&ldquo;<B>Incorporated Documents</B>&rdquo;) pursuant to Item 6 of Form S-3 which were filed under the Securities Exchange Act of
1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), on or before the date of this Agreement, or the issue date of the Base
Prospectus or the Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo;
&ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Base Prospectus or the
Prospectus Supplement shall be deemed to refer to and include the filing of any document under the Exchange Act after the date of
this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be, deemed to be incorporated
therein by reference. All references in this Agreement to financial statements and schedules and other information which is
&ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or
&ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus or the Prospectus Supplement (and all other references of
like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is
deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus Supplement, as the case
may be. No stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus or the Prospectus
Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s
knowledge, is threatened by the Commission. For purposes of this Agreement, &ldquo;<B>Free Writing Prospectus</B>&rdquo; has the
meaning set forth in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) <U>Assurances</U>.
The Registration Statement, as amended, (and any further documents to be filed with the SEC) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied
in all material respects with the Securities Act and the applicable Rules and Regulations and did not contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
The Preliminary Prospectus and the Prospectus, each as of its respective date, complies or will comply in all material respects with the
Securities Act and the applicable Rules and Regulations. Each of the Preliminary Prospectus and the Prospectus, as amended or supplemented,
did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Incorporated Documents,
when they were filed with the SEC, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules
and Regulations promulgated thereunder, and none of such documents, when they were filed with the SEC, contained any untrue statement
of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to Incorporated Documents
incorporated by reference in the Preliminary Prospectus or the Prospectus), in light of the circumstances under which they were made not
misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which
represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the
SEC. Except for this Agreement and the Transaction Documents, there are no documents required to be filed with the SEC in connection with
the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within
the requisite time period. Except for this Agreement and the Transaction Documents, there are no contracts or other documents required
to be described in the Preliminary Prospectus or the Prospectus, or to be filed as exhibits or schedules to the Registration Statement,
which have not been described or filed as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(c) <U>Offering
Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the
Closing Date, any offering material in connection with the offering and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(d) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;) are set forth in the Registration Statement.
The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any
liens, charges, security interests, encumbrances, rights of first refusal, preemptive rights or other restrictions (collectively, &ldquo;<B>Liens</B>&rdquo;),
and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(e) <U>Organization and
Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and , if applicable under the laws of the jurisdiction in which they are formed, in good standing under the laws of the jurisdiction
of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry
on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor in default of any of the
provisions of its respective certificate or articles of incorporation, memorandum of association, articles of association, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or
enforceability of this Agreement, the Transaction Documents or any other agreement or instrument relating to the Offering, (ii) a
material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the Company and the
Subsidiaries, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under this Agreement or the transactions contemplated under the Preliminary Prospectus (any of (i), (ii) or (iii), a
&ldquo;<B>Material Adverse Effect</B>&rdquo;); <I>provided </I>that a change in the market price or trading volume of the Common
Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse Effect. No action, claim, suit, investigation or
proceeding (including, without limitation, an informal inquiry), whether commenced or to the Company&rsquo;s knowledge, threatened
against the Company before any court, governmental agency or regulatory authority (&ldquo;<B>Proceeding</B>&rdquo;) has been
instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(f) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement, the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of each of this Agreement, the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby
and thereby and under the Preliminary Prospectus have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Company&rsquo;s Board of Directors or the Company&rsquo;s stockholders in connection therewith
other than in connection with the Required Approvals (as defined in the Securities Purchase Agreement). This Agreement and each Transaction
Document has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(g) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and each Transaction Document and the transactions
contemplated hereby and thereby, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s
certificate or articles of incorporation, memorandum of association, articles of association, bylaws or other organizational or charter
documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any
rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company
or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, (iii) subject to
the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities
laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each
of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(h) <U>Filings, Consents
and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make
any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of this Agreement and the transactions contemplated by the
Preliminary Prospectus, other than: (i) the filing with the SEC of the Prospectus Supplement and such other filings as are required
to be made under applicable federal and state securities laws, including the filing of Form D with the SEC and (ii) application(s)
to each applicable Trading Market for the listing of the Shares or as applicable, Pre-Funded Warrant Shares, for trading thereon in
the time and manner required thereby. As used herein (i) &ldquo;<B>Persons</B>&rdquo; means an individual or corporation,
partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any kind and (ii) &ldquo;<B>Affiliate</B>&rdquo; means any
Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(i) <U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the Prospectus,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(j) <U>Capitalization</U>.
The capitalization of the Company is as set forth in the Registration Statement. The Company has not issued any capital stock or Common
Stock Equivalents since its most recently filed SEC Report (as defined below), other than pursuant to the exercise of employee stock options
or vesting and settlement of restricted stock units under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock
to employees pursuant to any employee stock purchase plans and pursuant to the conversion and/or exercise of securities of the Company
or the Subsidiaries which would entitle the holder thereof to acquire at any time any Common Stock, including, without limitation, any
debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable
for, or otherwise entitles the holder thereof to receive, Common Stock (&ldquo;Common Stock Equivalents&rdquo;) outstanding as of the
date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right
of participation, or any similar right to participate in the transactions contemplated by this Agreement and the transactions contemplated
pursuant to the Preliminary Prospectus or the Prospectus. Except as a result of the purchase and sale of the Securities and except as
set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock
Equivalents or capital stock of any Subsidiary, except as set forth in the SEC Reports. The issuance and sale of the Securities will not
obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers and
the Placement Agent) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or
reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary that contain
any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws where applicable, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. Except for the Required Approvals, no further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(k) <U>SEC Reports;
Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed
by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one (1)
year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Preliminary
Prospectus, the Prospectus and any prospectus supplement, being collectively referred to herein as the &ldquo;<B>SEC
Reports</B>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with
the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading. The Company has never been an
issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in
effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles applied on a consistent basis during the periods involved (&ldquo;<B>GAAP</B>&rdquo;), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its
consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(l) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the Preliminary Prospectus or the Prospectus, except as disclosed in the Preliminary Prospectus or the Prospectus, as the case may be,
(i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse
Effect, (ii) except as disclosed in the SEC Reports, the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice, and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the SEC, (iii)
the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or
other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock,
and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity
incentive plans. Except as disclosed in the SEC Reports, the Company does not have pending before the SEC any request for confidential
treatment of information. Except for the issuance of the Securities contemplated or disclosed in the Preliminary Prospectus or the Prospectus
or as set forth in the SEC Reports, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably
expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation
is made. As used in this Agreement, &ldquo;<B>Trading Day</B>&rdquo; means a day on which the Trading Market (as defined below) is open
for trading. As used in this Agreement, &ldquo;<B>Trading Market</B>&rdquo; means The Nasdaq Capital Market, the securities exchange on
which the Common Stock is listed for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(m) <U>Litigation</U>.
Except as disclosed in the SEC Reports, there is no Proceeding pending or, to the knowledge of the Company, threatened against or affecting
the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency
or regulatory authority (federal, state, county, local or foreign) which (i) adversely affects or challenges the legality, validity or
enforceability of any of this Agreement, the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision,
have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Proceeding involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty which could have or reasonably be expected to result in a Material Adverse Effect. There has
not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation or informal inquiry by the SEC
or its Staff involving the Company or any current or former director or officer of the Company. The SEC has not issued any stop order
or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act
or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(n) <U>Labor
Relations</U>. (1) No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the
employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or
its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such
Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and
its Subsidiaries believe that their relationships with their employees are good. (2) No executive officer of the Company or any
Subsidiary, to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or
agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does
not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. (3) The Company
and its Subsidiaries are in compliance with all applicable U.S. federal, state, local, and foreign laws and regulations relating to
employment and employment practices, terms and conditions of employment, and wages and hours, except where the failure to be in
compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(o) <U>Compliance</U>.
In addition to Section 2(n), neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan, or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator,
or governmental authority, or (iii) is or has been in violation of any law, statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws, state unfair trade practice laws and rules and foreign
equivalents, taxes, environmental protection, occupational health and safety and product quality matters, except in each case as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(p) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits would not or could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<B>Material
Permits</B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(q) <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(r) <U>Patents
and Trademarks</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar
rights necessary or material for use in connection with their respective businesses as described in the Preliminary Prospectus and Prospectus
and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the
date of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary
has received, since the date of the latest audited financial statements included within the Preliminary Prospectus and the Prospectus,
a notice (written or otherwise) of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon
the rights of any Person, except as would not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(s) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, commercially reasonable directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(t) <U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the executive officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, executive officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any executive
officer, director or such employee or, to the knowledge of the Company, any entity in which any executive officer, director, or any such
employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000
other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of
the Company and (iii) other employee benefits, including equity award or option agreements under any equity incentive plan or similar
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(u) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by
the SEC thereunder that are effective as of the date hereof and as of the Closing Date. Except as disclosed in the Preliminary
Prospectus or the Prospectus, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP
and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or
specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. Except as disclosed in the SEC Reports, the Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be
disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the SEC&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the
effectiveness of the Company&rsquo;s disclosure controls and procedures of the Company and the Subsidiaries as of the end of the
period covered by the Company&rsquo;s most recently filed periodic report under the Exchange Act (such date, the
&ldquo;<B>Evaluation Date</B>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting
(as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably
likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(v) <U>Certain
Fees</U>. Except as set forth in the Preliminary Prospectus or the Prospectus, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company to any broker, dealer, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by this Agreement and the transactions contemplated pursuant to the
Preliminary Prospectus and the Prospectus. Other than for Persons engaged by any Purchaser, if any, Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section
2(v) that may be due in connection with the transactions contemplated by this Agreement and the transactions contemplated pursuant to
the Preliminary Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(w) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(x) <U>Registration
Rights</U>. Except as disclosed in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(y) <U>Listing and
Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the
Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such
registration. Except as disclosed in the SEC Reports, the Company has not, in the twelve (12) months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is
not in compliance with the listing or maintenance requirements of such Trading Market. Except as otherwise disclosed in the SEC
Reports, the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with
all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust
Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(z) <U>Application
of Takeover Protections</U>. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under this Agreement and the transactions contemplated pursuant to the Preliminary Prospectus, including without
limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(aa) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by this Agreement and the transactions contemplated
pursuant to the Preliminary Prospectus and the Prospectus, the Company confirms that neither it nor any other Person acting on its behalf
has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material,
non-public information which is not otherwise disclosed in the SEC Reports. The Company understands and confirms that the Purchasers will
rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on
behalf of the Company to the Purchasers regarding the Company and, its Subsidiaries, their respective businesses and the transactions
contemplated hereby, does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements made therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve (12) months preceding the date of this Agreement taken as a whole did not contain, at their respective
times of issuance, any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(bb) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Securities Purchase Agreement, neither the
Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be
integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of any Trading Market on
which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(cc) <U>Solvency</U>.
Except as disclosed in the Preliminary Prospectus or the Prospectus, based on the consolidated financial condition of the Company as
of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder,
(i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of
the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the
Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be
conducted including its capital needs taking into account the particular capital requirements of the business conducted by the
Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the
Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all
anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are
required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into
account the timing and amounts of cash to be payable on or in respect of its debt). Except as disclosed in the Preliminary
Prospectus or the Prospectus, the Company has no knowledge of any facts or circumstances which lead it to believe that it will file
for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from each Closing
Date. The SEC Reports discloses as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any
Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
&ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of Fifty Thousand Dollars
($50,000) (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements, and
other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the
Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in
excess of Fifty Thousand Dollars ($50,000) due under leases required to be capitalized in accordance with GAAP. Neither the Company
nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(dd) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries (i) has made or filed all applicable United States federal, state and local income and franchise and
all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports
and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such
claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(ee) <U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any Person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977 (the &ldquo;<B>FCPA</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">(ff) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(gg) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the terms of the
Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date
such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option
plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(hh) <U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firm is set forth in the Preliminary Prospectus and the Prospectus. To the
knowledge of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending
December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(ii) <U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent, as to which no
representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation
paid to the Company&rsquo;s placement agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(jj) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary, to the Company&rsquo;s knowledge, any director, officer, agent, employee or
Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(kk) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, and the Company shall so certify upon any Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(ll) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve</B>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(mm) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable United States federal
and state and foreign money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B>Money Laundering
Laws</B>&rdquo;), and no Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(nn) <U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to the Placement Agent shall be deemed to be a representation and warranty
by the Company to the Placement Agent as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(oo) <U>Reliance</U>. The
Company acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and warranties
and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(pp) <U>Forward-Looking
Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the SEC Reports has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(qq) <U>Statistical or Market-Related
Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the SEC Reports, are based
on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate, and such data agree with
the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(rr) <U>FINRA Affiliations</U>.
There are no affiliations with any firm that is a member of the FINRA participating in the Offering among the Company&rsquo;s officers,
directors or, to the knowledge of the Company, any 5% or greater stockholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(ss) <U>Board of Directors</U>.
The Company&rsquo;s Board of Directors is comprised of the persons identified as directors of the Company in the Preliminary Prospectus
or the Prospectus under the section titled &ldquo;Management.&rdquo; The qualifications of the persons serving as board members and the
overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable
to the Company and the rules of the Trading Market. At least one member of the Board of Directors qualifies as a &ldquo;financial expert&rdquo;
as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading Market.
In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as defined under
the rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(tt) <U>Cybersecurity</U>.
To the Company&rsquo;s knowledge, there has been no security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its
respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or
technology (collectively, &ldquo;<B>IT Systems and Data</B>&rdquo;) that would reasonably be expected to result in, individually or
in the aggregate, a Material Adverse Effect and (i) the Company and the Subsidiaries have not been notified of, and has no knowledge
of any event or condition that would reasonably be expected to result in, any material security breach or other compromise to its IT
Systems and Data except as would not, individually or in the aggregate for all such matters referred to in this clause (i), have a
Material Adverse Effect; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and
all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and
Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a
Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of
all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology
consistent with commercially reasonable industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(uu) <U>Compliance with
Data Privacy Laws</U>. To the Company&rsquo;s knowledge, (i) the Company and the Subsidiaries are, and at all times during the last
three (3) years were, in material compliance with all applicable state, federal and foreign data privacy and security laws and
regulations, including, without limitation, the European Union General Data Protection Regulation (&ldquo;<B>GDPR</B>&rdquo;) (EU
2016/679) (collectively, &ldquo;<B>Privacy Laws</B>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and
take appropriate steps reasonably designed to ensure compliance with their policies and procedures relating to data privacy and
security and the collection, storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the
&ldquo;<B>Policies</B>&rdquo;); (iii) the Company provides accurate notice of its applicable Policies to its customers, employees,
third party vendors and representatives as required by the Privacy Laws; and (iv) applicable Policies provide accurate and
sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject matter, and do not contain any
material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws. &ldquo;<B>Personal
Data</B>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social
security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other
piece of information that allows the identification of such natural person, or his or her family, or permits the collection or
analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws, except as
would not, individually or in the aggregate for all such matters referred to in this clause (i), have a Material Adverse Effect and
(ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or
Policies. Neither the Company nor the Subsidiaries, to the knowledge of the Company, (i) has received written notice of any actual
or potential liability of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries
of, any of the Privacy Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or
other corrective action pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order,
decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or
liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(vv) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or
subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;) into the
environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<B>Environmental Laws</B>&rdquo;); (ii) have received all permits licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of
any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 3. Delivery and Payment<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) <U>Closing for the
Offering</U>. Delivery of and payment for the Securities shall be made at or around 9:00 a.m., Eastern time, on or before the second
(2nd) Trading Day following the date of the Purchase Agreement. The Closing shall take place remotely by electronic transfer of the
Closing documentation. On the Closing Date, the Company shall issue such amount of Securities sold pursuant to the Purchase
Agreement directly to the accounts designated by the Placement Agent for the applicable Purchasers and payment shall be made by the
Purchasers by wire transfer to the Company. At the Closing, the Securities which the Company shall deliver to each Purchaser the
number of Shares and/or Pre-Funded Warrants purchased by such Purchaser. Subject to the terms and conditions hereof, at the Closing,
payment of the purchase price for the Securities sold pursuant to the Purchase Agreement shall be made by federal funds wire
transfer, against delivery of the Securities, and such Securities shall be registered in such name or names and shall be in such
denominations, as the Placement Agent may request. All actions taken at the Closing shall be deemed to have occurred simultaneously.
Deliveries of the documents with respect to the purchase of the Pre-Funded Warrants, if any, shall be made remotely by electronic
transfer; provided, however, that the Company shall be deemed to have satisfied its obligations with respect to the delivery of the
Pre-Funded Warrants by making available a PDF copy of the executed Pre-Funded Warrants at the Closing and delivering the originals
thereof within five (5) Trading Days of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) <U>Payment
for the Securities</U>. The Securities are being sold to the Purchasers at the public offering price as set forth in the Prospectus Supplement.
The purchase of the Securities by each of the Purchasers shall be evidenced by the receipt of funds in the account designated by the Company
and the Placement Agent and execution of a Purchase Agreement by each such Purchaser and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(c) <U>Delivery
of the Shares</U>. Delivery of the Shares shall be made through the facilities of The Depository Trust Company unless the Placement Agent
shall otherwise instruct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 4. Covenants and Agreements of the
Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) <U>Registration
Statement Matters</U>. During the Prospectus Delivery Period (as defined below), the Company will advise the Placement Agent promptly
after it receives notice thereof of the time when any amendment to the Registration Statement has been filed or becomes effective or any
supplement to the Prospectus has been filed and will furnish the Placement Agent with copies thereof. During the Prospectus Delivery Period
(as defined in Section 4(c), the Company will file promptly all reports and any definitive proxy or information statements required to
be filed by the Company with the SEC pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of any Prospectus.
During the Prospectus Delivery Period, the Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any
request by the SEC to amend the Registration Statement or to amend or supplement any Prospectus or for additional information, and (ii)
of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment
thereto or any order directed at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing or
suspending the use of the Prospectus or the Prospectus Supplement or any prospectus supplement or any amendment or supplement thereto
or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities for offering or
sale in any jurisdiction, of the institution or threatened institution of any Proceeding for any such purpose, or of any request by the
SEC for the amending or supplementing of the Registration Statement or a Prospectus or for additional information. The Company shall use
its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the SEC shall enter any such
stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts to obtain the lifting of
such order at the earliest possible moment, or will file a new registration statement and use its best efforts to have such new registration
statement declared effective as soon as practicable. Additionally, the Company agrees that during the Prospectus Delivery Period, it shall
comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the
timely filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such
Rule 424(b) are received in a timely manner by the SEC. The Company covenants and agrees to update the Prospectus Supplement to include
all information required to be included therein, including with respect to any SEC Reports that are filed subsequent to the date of the
Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) <U>Blue Sky
Compliance</U>. The Company will qualify or register the Offering under the securities laws of applicable jurisdictions (United
States and foreign) as the Placement Agent and the Purchasers may reasonably request and will make such applications, file such
documents, and furnish such information as may be reasonably required for that purpose, provided the Company shall not be required
to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction where it is not now so
qualified or required to file such a consent, and <U>provided further</U> that the Company shall not be required to produce any new
disclosure statement or take such action as is necessary for the Offering to be made pursuant to an available exemption from
qualification or registration in applicable jurisdictions. During the Prospectus Delivery Period, the Company will, from time to
time, prepare and file such statements, reports and other documents as are or may be required to continue such qualifications in
effect. During the Prospectus Delivery Period, the Company will advise the Placement Agent promptly of the suspension of the
qualification or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any
jurisdiction or any initiation or threat of any Proceeding for any such purpose, and in the event of the issuance of any order
suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at
the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(c) <U>Amendments
and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the rules
and regulations of the SEC thereunder, so as to permit the completion of the distribution of the Securities as contemplated in this Agreement,
the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required by law to be delivered in connection
with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus (the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;),
any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement Agent or Placement Agent&rsquo;s
Counsel, it becomes necessary to amend or supplement the Incorporated Documents or any Prospectus in order to make the statements therein,
in the light of the circumstances under which they were made, as the case may be, not misleading, or if it is necessary at any time to
amend or supplement the Incorporated Documents or any Prospectus or to file under the Exchange Act any Incorporated Document to comply
with any law, the Company will promptly prepare and file with the SEC, and furnish at its own expense to the Placement Agent and to dealers,
an appropriate amendment to the Registration Statement or supplement to the Registration Statement, the Incorporated Documents or any
Prospectus that is necessary in order to make the statements in the Incorporated Documents and any Prospectus as so amended or supplemented,
in the light of the circumstances under which they were made, as the case may be, not misleading, or so that the Registration Statement,
the Incorporated Documents or any Prospectus, as so amended or supplemented, will comply with law. Before amending the Registration Statement
or supplementing the Incorporated Documents or any Prospectus in connection with the Offering, the Company will furnish the Placement
Agent with a copy of such proposed amendment or supplement and will not file any such amendment or supplement to which the Placement Agent
reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(d) <U>Copies
of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during the period
beginning on the date hereof and ending on the Closing Date of the Offering, as many copies of any Prospectus or Prospectus supplement
and any amendments and supplements thereto, as the Placement Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(e) <U>Free
Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make
any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &ldquo;<B>Free
Writing Prospectus</B>&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the SEC or retained
by the Company under Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in writing to any such Free
Writing Prospectus (a &ldquo;<B>Permitted Free Writing Prospectus</B>&rdquo;), the Company covenants that it shall (i) treat each Permitted
Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities
Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the SEC, legending and record keeping.
Notwithstanding anything herein to the contrary, in no event shall the Company make any offer or communication relating to the Offering
which meets the definition of a &ldquo;Free Writing Prospectus&rdquo; while the Company is an &ldquo;ineligible issuer&rdquo; (as such
terms are defined in Rule 405 of the Securities Act) or otherwise in contravention of the Securities Act and the Rules and Regulations
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)
<U>Transfer Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(g) <U>Earnings
Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later
than 12 months after the Closing Date, the Company will make generally available to its security holders and to the Placement Agent an
earnings statement, covering a period of at least 12 consecutive months beginning after the Closing Date, that satisfies the provisions
of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Periodic
Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the SEC and the
Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required
by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(i) <U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the
Purchasers deem necessary or appropriate to consummate the Closing in connection with the Offering, all of which will be in form and substance
reasonably acceptable to the Placement Agent and the Purchasers. The Company agrees that the Placement Agent may rely upon the representations
and warranties, and applicable covenants set forth in any Transaction Document including the Purchase Agreement entered into with Purchasers
in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(j) <U>No
Manipulation of Price</U><I>.</I> The Company will not take, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(k) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent&rsquo;s prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(l) <U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing, make public its involvement
with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(m) <U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(n) <U>Research
Matters</U>. By entering into this Agreement, the Placement Agent provides no promise, either explicitly or implicitly, of favorable or
continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent&rsquo;s selection as
the placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent&rsquo;s providing favorable
or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent
has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research,
a rating or a price target, to the Company or inducement for the receipt of business or compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> (p) <U>Subsequent Equity Sales</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) From
the date hereof until sixty (60) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents, except for the securities issued
pursuant hereto, the filing of any amendment or supplement to an existing registration statement for an &ldquo;at the market&rdquo; offering
with the Placement Agent as sales agent, or filing a registration statement on Form S-8 in connection with any employee benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) From the
date hereof until sixty (60) days after the Closing Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a
transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at
any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is
subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of
specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or
(ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an
&ldquo;at-the- market offering&rdquo;, whereby the Company may issue securities at a future determined price regardless of whether
shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled, <U>provided</U>, <U>however</U>,
that, after 30 days after the Closing Date, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the
market&rdquo; offering with the Placement Agent as sales agent shall not be deemed a Variable Rate Transaction. The Placement Agent
shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition
to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) Notwithstanding
the foregoing, Section 4(p)(i) and (ii) shall not apply in respect of an Exempt Issuance. An &ldquo;<B>Exempt Issuance </B>&rdquo; means
the issuance of (A) shares of Common Stock or options or other securities to employees, officers, directors or consultants of the Company
pursuant to any employee benefit plan, equity incentive plan or other employee compensation plan existing on the date hereof or any stock
or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the
members of a committee of non-employee directors established for such purpose for services rendered to the Company, (B) Common Stock issued
upon the exercise or exchange of or conversion of any Securities issued pursuant to the Securities Purchase Agreement or Prospectus or
this Agreement and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding
on the date of this Agreement provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection
with stock splits or combinations or anti-dilution provisions contained therein as disclosed in the SEC Reports and the Prospectus) or
to extend the term of such securities, or securities issuable in connection with a transaction involving the Company and existing stockholders
in which the Company offers the existing stockholders the option to exchange their shares of Common Stock for other securities of the
Company, (C) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period
in Section 4(p)(i) herein, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which
is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the
Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities, and (D) the issuance of the Securities in the Offering, and (E) the entry into and/or issuance of shares of Common Stock
pursuant to a Regulation A+ offering with the Placement Agent as sales agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)
<U>Tail Fee</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(i) <U>Tail
Fee</U>. The Company and the Placement Agent agree that for a period of twelve (12) months from (i) the Closing Date of the Offering or
(ii) if the Closing does not occur, the termination of this Agreement by the Company other than for Cause, the Placement Agent shall be
entitled to compensation commensurate with those set forth under Section 1(a) (the &ldquo;<B>Tail Fee</B>&rdquo;), from the sale of any
equity, debt and/or equity derivative instruments to any investor actually introduced by the Placement Agent to the Company, but unknown
to the Company prior to such introduction, during the period between the date of this Agreement and the Closing of the Offering or the
termination of this Agreement, as applicable (each, a &ldquo;<B>Tail Financing</B>&rdquo;), and such Tail Financing is consummated at
any time within the twelve (12) month period from the Closing Date of the Offering or termination of this Agreement, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(ii) <U>Termination
for Cause</U>. Notwithstanding anything herein to the contrary, in accordance with FINRA Rule 5110(g)(5)(B), this Section 4(q) and the
Tail Fee contemplated hereby may be terminated by the Company for &ldquo;Cause&rdquo;, which shall mean a material breach by the Placement
Agent of this Agreement or a material failure by the Placement Agent to provide the services as contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Securities Laws
Disclosure; Publicity</U>. The Company shall (i) issue a press release disclosing the material terms of the transactions
contemplated hereby at the date and time agreed upon by the Company and the Placement Agent, and (ii) file a Current Report on Form
8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act. From and
after the issuance of such press release, the Company represents that it shall have publicly disclosed all material, non-public
information delivered by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, in connection with the transactions contemplated by the Transaction Documents. The Company and the Placement
Agent shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(s) <U>Future
Services</U>. The Company and the Placement Agent agree that for a period of eighteen (18) months from the closing date of the Offering,
the Company grants the Placement Agent the right to provide investment banking services to the Company on an exclusive basis in the matters
below, for which investment banking services are sought by the Company (such right, the &ldquo;Right of First Refusal&rdquo;), which right
is exercisable in the Placement Agent&rsquo;s sole discretion. For these purposes, investment banking services shall include, (a) acting
as lead or joint-lead manager for any underwritten public offering; (b) acting as lead or joint book-runner and/or lead or joint placement
agent, initial purchaser in connection with any private offering of securities of the Company; and (c) acting as financial advisor in
connection with any sale or other transfer by the Company, directly or indirectly, of a majority or controlling portion of its capital
stock or assets to another entity, any purchase or other transfer by another entity, directly or indirectly, of a majority or controlling
portion of the capital stock or assets of the Company, and any merger or consolidation of the Company with another entity. The Placement
Agent shall notify the Company of its intention to exercise the Right of First Refusal within 15 business days following notice in writing
by the Company. Any decision by the Placement Agent to act in any such capacity shall be contained in separate agreements, which agreements
would contain, among other matters, provisions for customary fees for transactions of similar size and nature, as may be mutually agreed
upon, and indemnification of the Placement Agent and shall be subject to general market conditions. In compliance with FINRA Rule 5110(g)(6)(A),
in no circumstances the Right of First Refusal shall have a duration of more than three years from the commencement of sales of the public
offering or the termination date of the engagement between the Company and Univest. If the Placement Agent declines to exercise the Right
of First Refusal, the Company shall have the right to retain any other person or persons to provide such services on terms and conditions
which are not more favorable to such other person or persons than the terms declined by Univest. The Right of First Refusal granted hereunder
may be terminated by the Company for &ldquo;Cause,&rdquo; which shall mean a material breach by the Placement Agent of this Agreement
or a material failure by the Placement Agent to provide the services as contemplated by this Agreement. The services provided by Univest
hereunder are solely for the benefit of the Company and are not intended to confer any rights upon any persons or entities not a party
hereto (including, without limitation, securityholders, employees or creditors of the Company) as against Univest or its directors, officers,
agents and employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 5. Conditions of the Obligations of
the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the accuracy of the representations and
warranties on the part of the Company set forth in <U>Section 2</U> hereof, in each case as of the date hereof and as of the Closing Date
as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder, and to each of
the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)
<U>Reserved.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) <U>Compliance
with Registration Requirements; No Stop Order; No Objection from FINRA</U>. Each Prospectus (in accordance with Rule 424(b)) and Free
Writing Prospectus if any, shall have been duly filed with the SEC, as appropriate; no stop order suspending the effectiveness of the
Registration Statement or any part thereof shall have been issued and no Proceeding for that purpose shall have been initiated or threatened
by the SEC; no order preventing or suspending the use of any Prospectus shall have been issued and no Proceeding for that purpose shall
have been initiated or threatened by the SEC; no order having the effect of ceasing or suspending the distribution of the Securities or
any other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange
and no Proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated by
any securities commission, securities regulatory authority or stock exchange; all requests for additional information on the part of the
SEC shall have been complied with; and FINRA shall have raised no objection to the fairness and reasonableness of the placement terms
and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(c) <U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and each
Prospectus, and the registration, sale, and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory
to the Placement Agent&rsquo;s Counsel, and such counsel shall have been furnished with such papers and information as it may reasonably
have requested to enable such counsel to pass upon the matters referred to in this Section 5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Placement
Agent&rsquo;s reasonable judgment after consultation with the Company, there shall not have occurred any material adverse change or development
involving a prospective material adverse change in the condition or the business activities, financial or otherwise, of the Company from
the latest dates as of which such condition is set forth in the Registration Statement and Prospectus (each, a &ldquo;<B>Material Adverse
Change</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in"> (e) <U>Opinions of Counsel for the Company</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Except as otherwise
waived or indicated below, the Placement Agent shall have received on the Closing Date the written opinions from US, Wyoming and Chinese
legal counsels to the Company, dated as of the Closing Date and addressed to the Placement Agent, including, without limitation, a negative
assurance letter addressed to the Placement Agent and, in form and substance satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(f) <U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated as of the Closing Date
and which may be relied upon by the Placement Agent, signed by the Chief Executive Officer and Chief Financial Officer of the Company,
in their respective capacities as such officers only, in a form satisfactory to the Placement Agent, to the effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) The
representations and warranties of the Company in this Agreement are true and correct in all material respects (except such representations
and warranties which are qualified by materiality or by Material Adverse Effect, which shall be true and correct in all respects), as
if made on and as of the Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part
to be performed or satisfied at or prior to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) No
stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no Proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued by
any securities commission, securities regulatory authority or stock exchange in the United States and no Proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) When
the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate,
the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the SEC, and
any Prospectus, contained all material information required to be included therein by the Securities Act and the Exchange Act and the
applicable rules and regulations of the SEC thereunder, as the case may be, and in all material respects conformed to the requirements
of the Securities Act and the Exchange Act and the applicable rules and regulations of the SEC thereunder, as the case may be, and the
Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties
contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date of the Registration
Statement, there has occurred no event required by the Securities Act and the rules and regulations of the SEC thereunder to be set forth
in the Incorporated Documents which has not been so set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)
Subsequent to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and
any Prospectus, there has not been: (i) any Material Adverse Change; (ii) any transaction that is material to the Company and the
Subsidiaries taken as a whole, except transactions entered into in the ordinary course of business; (iii) any obligation, direct or
contingent, that is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except
obligations incurred in the ordinary course of business; (iv) any material change in the capital stock (except changes thereto
resulting from the exercise of outstanding stock options or warrants) or outstanding indebtedness of the Company or any Subsidiary;
(v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company; or (vi) any loss or damage
(whether or not insured) to the property of the Company or any Subsidiary which has been sustained or will have been sustained which
has a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(g) <U>Chief
Financial Officer&rsquo;s Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company,
dated as of the Closing Date and which may be relied upon by the Placement Agent, signed by the Chief Financial Officer of the Company,
with respect to certain financial data contained in or incorporated by reference into the Registration Statement, in a form satisfactory
to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(h) <U>Secretary&rsquo;s
Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated as of the Closing Date
and which may be relied upon by the Placement Agent, signed by the Secretary of the Company, certifying, among others, (i) that each of
the Company&rsquo;s Amended and Restated Certificate of Incorporation and Amendment No. 1 to Amended Bylaws, and all amendments thereto,
is true and complete, has not been modified and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of
Directors relating to the Offering are in full force and effect and have not been modified; (iii) that each of the Company and its Subsidiaries
is in good standing under the laws of the jurisdiction of its incorporation or organization; (iv) as to the accuracy and completeness
of all correspondence between the Company or its counsel and the SEC; and (v) as to the incumbency of the officers of the Company, in
a form reasonably acceptable to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(i) <U>Exchange
Act Registration and Stock Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the
Trading Market, and the Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the
registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market,
nor shall the Company have received any information suggesting that the SEC or the Trading Market is contemplating terminating such registration
or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(j) <U>Additional
Documents</U>. On or before the Closing Date, the Placement Agent and Placement Agent&rsquo;s Counsel shall have received such information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as
contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of
the conditions or agreements, herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">If any condition specified
in this <U>Section 5</U> is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent
by notice to the Company at any time on or prior to the Closing Date, which termination shall be without liability on the part of any
party to any other party, except that <U>Section 1(a)</U>, <U>Section 1(b)</U>, <U>Section 6</U> (Payment of Expenses), <U>Section 7</U>
(Indemnification and Contribution) and <U>Section 8</U> (Representations and Indemnities to Survive Delivery) shall at all times be effective
and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 6. Payment of Fees and Expenses</B>.
Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company agrees to pay all costs, fees and expenses incurred by the Company in
connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without
limitation: (i) payment to the Placement Agent of its Cash Fee and non-accountable expense allowance (ii) all expenses incident to the
issuance, delivery and qualification of the Securities (including all printing and engraving costs); (iii) all fees and expenses of the
registrar and transfer agent of the Common Stock; (iv) all necessary issue, transfer and other stamp taxes in connection with the issuance
and sale of the Securities; (v) all fees and expenses of the Company&rsquo;s counsel, registered independent public accounting firm and
other advisors; (vi) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of
the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Prospectus
and the Prospectus Supplement, if any, and all amendments and supplements thereto, and this Agreement; (vii) all filing fees, reasonable
attorneys&rsquo; fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from
the qualification or registration of) all or any part of the Securities for offer and sale under the state securities or blue sky laws
or the securities laws of any other country; (viii) the filing fees incident to the review and approval by FINRA of the Placement Agent&rsquo;s
participation in the offering and distribution of the Securities; (ix) the fees and expenses associated with the Securities on the Trading
Market; (x) all costs and expenses incident to the travel and accommodation of the Company&rsquo;s employees on the &ldquo;roadshow,&rdquo;
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 7. Indemnification and Contribution<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) The Company agrees to
indemnify and hold harmless the Placement Agent, its Affiliates and each Person controlling the Placement Agent, and the directors,
officers, agents and employees of the Placement Agent, their respective affiliates and each such controlling person (the Placement
Agent, and each such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;) from and against any losses, claims, damages,
judgments, assessments, costs and other liabilities (collectively, the &ldquo;<B>Liabilities</B>&rdquo;), and shall reimburse each
Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for all Indemnified Persons,
except as otherwise expressly provided herein) (collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an
Indemnified Person in investigating, preparing, pursuing or defending any Proceedings, whether or not any Indemnified Person is a
party thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement, any Incorporated Document, or any Prospectus or by any omission or alleged
omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged omissions from,
information relating to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person expressly for use in
the Registration Statement, any Incorporated Document, or any Prospectus) or (ii) otherwise arising out of or in connection with
advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated
thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or transactions; <U>provided</U>, <U>however</U>,
that, in the case of clause (ii) only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified
Person that are finally judicially determined to have resulted solely from such Indemnified Person&rsquo;s (x) gross negligence or
willful misconduct in connection with any of the advice, actions, inactions or services referred to above or (y) use of any offering
materials or information concerning the Company in connection with the offer or sale of the Securities in the Offering which were
not authorized for such use by the Company and which use constitutes gross negligence or willful misconduct. The Company also agrees
to reimburse each Indemnified Person for all Expenses as they are incurred in connection with enforcing such Indemnified
Person&rsquo;s rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(b) Upon
receipt by an Indemnified Person of actual notice of an Proceeding against such Indemnified Person with respect to which indemnity may
be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agent, assume the defense of any such Proceeding including the employment of counsel reasonably satisfactory
to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties
to any such Proceeding (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Proceeding or related Proceedings, in addition to any local counsel. The Company shall not be liable for
any settlement of any Proceeding effected without its written consent (which shall not be unreasonably withheld). In addition, the Company
shall not, without the prior written consent of the Indemnified Person (which shall not be unreasonably withheld), settle, compromise
or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened Proceeding in respect of which indemnification
or contribution may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise,
consent or termination includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Proceeding
for which indemnification or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is
due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) In
the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other hand,
of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as
well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of fees
actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the Company,
on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed to be in
the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by the Company
in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated, bears
to (b) the fees paid to the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty
of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(d) The
Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted solely
from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions or
services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(e) The
reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 8. Representations and Indemnities
to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the Company or any
person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement will remain
in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any of its or their
partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment for the Securities
sold hereunder and any termination of this Agreement. A successor to the Placement Agent, or to the Company, its directors or officers
or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 9. Notices</B>. All communications
hereunder shall be in writing and shall be overnight, next business day delivery, hand delivered or e-mailed and confirmed to the parties
hereto as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Placement Agent to the address
set forth above, attention: Yi (Edric) Guo, Chief Executive Officer, e-mail: yguo@univest.us</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Next Technology Holding Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Room 519,
05/F Block T3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Qianhai Premier Finance Centre Unit 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Guiwan Area, Nanshan District, Shenzhen,
China 518000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Attn: Weihong Liu</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">Email: Contact@nxtttech.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left"><I>With a copy (which shall not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left">McLaughlin &amp; Stern, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left">260 Madison
Ave., 18th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left">New York, NY 10016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: left">Attn: Steven Schuster</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: 0pt; text-align: left">&nbsp;&nbsp;&nbsp;Zhaocong &ldquo;Richard&rdquo; Xu</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: 0pt">Email: SSCHUSTER@mclaughlinstern.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: left; text-indent: 0pt">&nbsp;&nbsp;&nbsp;RXu@mclaughlinstern.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: .5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 10. Successors</B>. This Agreement
will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors and controlling
persons referred to in Section 7 hereof, and to their respective successors, and personal representative, and no other person will have
any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 11. Partial Unenforceability</B>. The
invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined
to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to
make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section 12. Governing Law Provisions; Exclusive
Jurisdiction</B>. This Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction,
effect and in all other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof.
Each of the Placement Agent and the Company: (i) agrees that any legal suit, action or Proceeding arising out of or relating to this Agreement
and/or the transactions contemplated hereby shall be instituted exclusively in the New York Supreme Court, County of New York, or in the
United States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue
of any such suit, action or Proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or Proceeding. Each of the Placement
Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action
or Proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every
respect effective service of process upon the Company, in any such suit, action or Proceeding, and service of process upon the Placement
Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service process upon
the Placement Agent, in any such suit, action or Proceeding. If either party shall commence an action or Proceeding to enforce any provision
of this Agreement, then the prevailing party in such action or Proceeding shall be reimbursed by the other party for its reasonable attorney&rsquo;s
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 13. General Provisions<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">(a) This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or more
counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same
instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express
or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein are for
the convenience of the parties only and shall not affect the construction or interpretation of this Agreement. If any provision contained
in this Agreement is in conflict with, or inconsistent with, any provision in that certain Securities Purchase Agreement dated as of September
2, 2025 (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;), by and between the Company and the purchasers listed on the signature
page thereto, the terms of the Securities Purchase Agreement shall govern and control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company
acknowledges that in connection with the Offering of the Securities: (i) the Placement Agent has acted at arm&rsquo;s length, is not
an agent of, and owes no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those
duties and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the
Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent
arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: center">[<I>The remainder of this page has been
intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>Next Technology Holding Inc. </B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">/s/ Wei Hong Liu</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD>Wei Hong Liu</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">Accepted and agreed to as of the date first written above:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>Univest Securities, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Yi (Edric) Guo</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Yi (Edric) Guo</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea025617901ex4-1_nexttech.htm
<DESCRIPTION>FORM OF THE PRE-FUNDED WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.05pt"><B>TO
PURCHASE COMMON STOCK OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.05pt"><B>NEXT TECHNOLOGY HOLDING INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">Warrant Shares: 34,686,744</TD>
    <TD STYLE="text-align: right; width: 40%; font-size: 10pt">Initial Exercise Date: September 2, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -35.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt">THIS PRE-FUNDED WARRANT TO PURCHASE
COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Lioness Limited or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;),
but not thereafter, to subscribe for and purchase from Next Technology Holding Inc., f/k/a WeTrade Group Inc., a Wyoming corporation (the
&ldquo;<U>Company</U>&rdquo;), up to 34,686,744 shares of Common Stock (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;).
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). Capitalized
terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &ldquo;Purchase
Agreement&rdquo;), dated September 2, 2025, among the Company and the signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt"><U>Section 1. Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the VWAP of the Common Stock for
such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the
fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority
in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, no par value per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-3, as amended (File No. 333-267362), which became effective
on September 16, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo; means a day on which the
Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the
Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><U>Section 2. Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy
submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <FONT STYLE="text-decoration: underline solid"><B>Exhibit
A</B></FONT> (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as
aforesaid, the Holder shall deliver the aggregate Exercise Price for the number of Warrant Shares specified in the applicable Notice
of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor
shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the
Holder has purchased all of the Warrant Shares purchasable hereunder and the Warrant has been exercised in full, at which time the
Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final
Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total
number of Warrant Shares purchasable hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder by the number of Warrant Shares equal to the applicable number of Warrant Shares purchased in connection with
such partial exercise. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date
of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 9:00 a.m. (New York City
time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the
Company agrees to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Initial Exercise Date, and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant
Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares
available for purchase hereunder at any given time will be less than the amount stated on the face hereof. </B>For the avoidance of
doubt, there is no circumstance that would require the Company to net cash settle the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per Warrant Share under this Warrant shall be $0.001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Cashless
Exercise</U>. Notwithstanding anything to the contrary set forth herein, if at the time of exercise hereof there is no effective registration
statement registering, or the prospectus contained therein is not available for the issuance of, the Warrant Shares to the Holder, then
this Warrant may only be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(A) = as applicable: (i)
the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule
600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of
the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the
close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the
applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed
and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(B) = the Exercise Price, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(X) = the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any
position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in"> (d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted to the Holder by
crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit
or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there
is an effective registration statement permitting the issuance of the Warrant Shares to, or resale of, the Warrant Shares by Holder or
(B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of the Warrant Shares, registered in the
Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares set forth in the Notice of
Exercise to the address specified by the Holder in such Notice of Exercise by the date that is the earliest of (i) three (3) Trading Days
after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to
the Company, and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall
be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has
been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other
than in the case of a cashless exercise) is received within the earlier of (i) three (3) Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder
in cash for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;) that is a participant in the FAST program so
long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard
settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock
as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">iii.&nbsp;<U>Rescission
Rights</U>. Except in connection with an exercise on the Initial Exercise Date, if the Company fails to cause the Transfer Agent to transmit
to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to
rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">iv.&nbsp;<U>Compensation for
Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of
Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is
required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise
purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the
amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the Warrant
Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to
deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and
delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In
and, upon request of the Company, evidence satisfactory to the Company with respect to the amount of such loss. Nothing herein shall
limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver
Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon the
exercise of this Warrant. As to any fraction of a Warrant Share which the Holder would otherwise be entitled to purchase upon such exercise,
the Company shall in lieu of the issuance of such fractional Warrant Share round up to the next whole Warrant Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, the Notice of
Exercise shall be accompanied by the Assignment Form, attached hereto as <FONT STYLE="text-decoration: underline solid"><B>Exhibit B</B></FONT>,
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any
transfer tax incidental thereto and this Warrant shall be surrendered to the Company and, if any portion of this Warrant remains unexercised,
a new Warrant in the form hereof shall be delivered to the assignee. The Company shall pay all Transfer Agent fees required for same-day
processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing
similar functions) required for same-day electronic delivery of the Warrant Shares.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise all or any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance upon exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s
Affiliates, (ii) any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any
other Persons whose beneficial ownership of shares of Common Stock would or could be aggregated with the Holder&rsquo;s for the
purposes of Section 13(d) (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock
issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of the
Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned
by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a
limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in
compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of
Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or
confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with
the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding Ordinary Shares that was
provided by the Company. In addition, a determination as to any group status as contemplated above shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder and the Company shall have no obligation
to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in
compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding Ordinary
Shares that was provided by the Company. For purposes of this Section 2(e), in determining the number of outstanding shares of
Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most
recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to
the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was
reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a
result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owed to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><U>Section 3. Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii)
subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split)
outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be
the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of
this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant remains unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or reclassification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -15.45pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in"> (b) [RESERVED]</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale
of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined
for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a
&ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be
entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is
taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to
participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall
not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as
a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the
Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the
holders of more than 50% of the outstanding shares of Common Stock of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of shares of Common Stock or any
compulsory share exchange pursuant to which shares of Common Stock are effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50%
of the outstanding shares of Common Stock of the Company (not including any shares of Common Stock held by the other Person or
Persons making or party to, or associated or affiliated with the other Persons making or party two, such stock or share purchase
agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise
of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction (and in the same proportion), at the option of the Holder
(without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the
successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to
any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the
Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of
the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any
exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent
entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and
such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of
such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share of Common Stock, as the case
may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -15.55pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in"> (g) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">ii.&nbsp;<U>Notice to Allow
Exercise by Holder</U>. If (A) the Company declares a dividend (or any other distribution in whatever form) on the shares of Common
Stock, (B) the Company declares a special nonrecurring cash dividend on or a redemption of the shares of Common Stock, (C) the
Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase any
shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company is required in connection
with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or winding up of
the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or
effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the
shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become
effective or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled
to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice, <I>provided,
further</I> that no notice shall be required if the information is disseminated in a press release or document filed with the
Commission within such time period. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><U>Section 4. Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto as <FONT STYLE="text-decoration: underline solid"><B>Exhibit
B</B></FONT> duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><U>Section 5. Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in
case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such
Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares underlying this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued, and the Warrant Shares, delivered, as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares underlying this Warrant, which may be issued upon the exercise of the purchase rights represented by
this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise
Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt">(f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and if the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws and in such case, the Holder,
by the acceptance hereof, represents and warrants that the Holder will acquire such Warrant Shares issuable upon such exercise for its
own account and not with a view to or for distributing or reselling Warrant Shares or any part thereof in violation of the Securities
Act or any applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Nonwaiver and
Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a
waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate
proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.75pt">(h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Currency</U>.
All dollar amounts referred to in this Warrant are in United States Dollars (&ldquo;<U>U.S. Dollars</U>&rdquo;). All amounts owing under
this Warrant shall be paid in U.S. Dollars. All amounts denominated in other currencies shall be converted in the U.S. Dollar equivalent
amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<U>Exchange Rate</U>&rdquo; means, in relation to any amount
of currency to be converted into U.S. Dollars pursuant to this Warrant, the U.S. Dollar exchange rate as published in the Wall Street
Journal (NY edition) on the relevant date of calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.2pt">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.2pt">(Signature Page Follows)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.2pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>NEXT TECHNOLOGY HOLDING INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD>Wei Hong Liu</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 31.3pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">TO: <B>NEXT TECHNOLOGY HOLDING INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full),
and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> (2) Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&#9744; in lawful money of the United States; or</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&#9744; if permitted
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The Warrant Shares shall be delivered to the following DWAC
Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">[SIGNATURE OF HOLDER]</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Name of Investing Entity</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity</I></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Name of Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Title of Authorized Signature</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Date</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.1pt"><B>EXHIBIT
B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.1pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.1pt"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.35pt">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-size: 10pt">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Email Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Dated:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Holder&rsquo;s&nbsp;Signature:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Holder&rsquo;s Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea025617901ex5-1_nexttech.htm
<DESCRIPTION>OPINION OF MCLAUGHLIN & STERN, LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>McLaughlin
&amp; Stern, llp</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>Founded
1898</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; text-align: center"><FONT STYLE="font-size: 10pt"><B>STEVEN W. SCHUSTER</B></FONT></TD>
    <TD STYLE="width: 33%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Partner</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">sschsuter@mclaughlinstern.com</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">New York, New York</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(212) 448-6216</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">260 Madison Avenue</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">Millbrook, New York</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">New York, New York 10016</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">Garden city, New York</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>RICHARD XU</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(212) 448&ndash;1100</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">Westport, Connecticut</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Partner</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">FAX (212) 448&ndash;0066</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">West Palm Beach, Florida</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">RXu@mclaughlinstern.com</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">www.mclaughlinstern.com</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">Westfield, New Jersey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(212) 448-6233</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt">September 3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>NEXT TECHNOLOGY HOLDING INC.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Room 519, 05/F Block T3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Qianhai Premier Finance Centre Unit 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Guiwan Area, Nanshan
District, Shenzhen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">People&rsquo;s Republic of China 518000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in">RE: Next Technology Holding Inc. (the &ldquo;Company&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Dear Sirs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We are acting as counsel to Next Technology
Holding Inc., f/k/a WeTrade Group Inc., a Wyoming corporation (the &ldquo;Company&rdquo;), in connection with the issuance and sale of
(i) an aggregate of 25,313,256 shares of common stock (the &ldquo;Shares&rdquo;) of the Company, no par value per share (the &ldquo;Common
Stock&rdquo;), and (ii) pre-funded warrants (the &ldquo;Pre-Funded Warrants&rdquo;) to purchase an aggregate of up to 34,686,744 shares
of Common Stock (the &ldquo;Pre-Funded Warrant Shares&rdquo;), pursuant to a Securities Purchase Agreement, dated as of September 2, 2025,
between the Company and certain purchaser named therein (the &ldquo;Purchaser&rdquo;) in an amount identified on the signature pages thereto
(the &ldquo;Purchase Agreement&rdquo;). The Shares, the Pre-Funded Warrants, and the Pre-Funded Warrant Shares are collectively referred
to herein as the &ldquo;Securities.&rdquo; The Company and Univest Securities, LLC (the &ldquo;Placement Agent&rdquo;) have entered into
a placement agency agreement, dated September 2, 2025 (the &ldquo;Placement Agency Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company registered the sale of the Shares,
the Pre-Funded Warrants, and Pre-Funded Warrant Shares, to be issued and sold pursuant to the Placement Agency Agreement, Purchase
Agreement and the Pre-Funded Warrants by means of a prospectus supplement filed with the U.S. Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on September 3, 2025 (the &ldquo;Prospectus Supplement&rdquo;), related to a registration statement (the
&ldquo;Registration Statement&rdquo;) on Form S-3, as amended (File No. 333-267362) under the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;), initially filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on
September 9, 2022 and became effective on September 16, 2022, including the base prospectus (the &ldquo;Base Prospectus&rdquo;). All
capitalized terms used herein and not expressly defined herein have the definitions specified in the Placement Agency Agreement and
the Purchase Agreement, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In connection with the issuance and
sale of the Securities, we have reviewed and relied upon, without independent verification, such matters and documents, and the representations
contained therein, as we have deemed necessary to render the opinions set forth below. Such documents include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">The Registration Statement;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">The Base Prospectus;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">The Prospectus Supplement;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">Resolutions of the Board of Directors of the Company (the
&ldquo;Board&rdquo;) approving this transaction;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">An opinion letter issued by Long Reimer Winegar LLP, dated
September 3, 2025 (the &ldquo;Wyoming Opinion&rdquo;);</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify">The Purchase Agreement, dated September 2, 2025;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">7.</TD><TD STYLE="text-align: justify">The Placement Agency Agreement, dated September 2, 2025;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">8.</TD><TD STYLE="text-align: justify">The Pre-Funded Warrants;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">9.</TD><TD STYLE="text-align: justify">The Lock-Up Agreements;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">10.</TD><TD STYLE="text-align: justify">The Company&rsquo;s filings on the SEC&rsquo;s website via
EDGAR and which are incorporated by reference in the Registration Statement; and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">11.</TD><TD STYLE="text-align: justify">Such statutes, records and other documents as we have deemed
relevant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We assume that there exists no provision
of any document other than those we have reviewed that bears upon or is inconsistent with this opinion. In addition, we have not conducted
any independent factual investigation of our own, but rather have relied solely upon the foregoing documents furnished for our review
as listed above, the statements of facts and factual information set forth in said documents, and the additional matters recited or assumed
herein, all of which we assume to be true, complete and accurate in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For purposes of this opinion we have
relied upon and assumed the accuracy of the foregoing and the facts set forth in the foregoing documents. We have assumed: (i) the validity
and accuracy of the documents and corporate records that we have examined, (ii) the genuineness of all signatures, (iii) the legal capacity
of all natural persons, (iv) the authenticity of all documents submitted to us as originals, (v) the conformity to original documents
of all documents submitted to us as certified or photostatic copies, and (vi) the authenticity of the originals of such documents. As
to any facts material to the opinion expressed herein that we did not independently establish or verify, we have relied upon statements
and representations of officers and other representatives of the Company and have assumed that such statements and representations are
true, correct and complete without regard to any qualification as to knowledge or belief. Our opinion is conditioned upon, among other
things, the initial and continuing truth, accuracy, and completeness of the items described above on which we are relying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We are members of the Bar of New York
and do not express any opinion as to matters governed by any laws other than the internal laws of the State of New York and the federal
laws of the United States. We express no opinion concerning any matters respecting or affected by any laws other than laws that a lawyer
in New York exercising customary professional diligence would reasonably recognize as being directly applicable to the transactions contemplated
by the Placement Agency Agreement, the Purchase Agreement, and the Pre-Funded Warrants (collectively, the &ldquo;Transaction Documents&rdquo;).
When any opinion is given herein with respect to an issue where any law other than the laws of the State of New York may apply, the opinion
assumes that consideration of the laws of such jurisdiction would lead to the same result as consideration of the laws of the State of
New York. For purposes of our opinions, we have assumed that the Transaction Documents and the Material Contracts (as defined in opinion
3) are governed exclusively by the internal, substantive laws and judicial interpretations of the State of New York. We express no opinion
as to any county, municipal, city, town or village ordinance, rule, regulation or administrative decision. We express no opinion with
respect to agreements to submit to the jurisdiction of any particular court or other governmental authority (either as to personal jurisdiction
or subject matter jurisdiction); waiver of service or process requirements, which would otherwise be applicable; and provisions otherwise
relating to jurisdiction, service of process or venue of courts. In particular, we express no opinion as to matters governed by Wyoming
law, which are addressed by the Wyoming Opinion</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Based upon and subject to the foregoing,
we are of the opinion that each of the Pre-Funded Warrants, if and when issued, delivered and paid for as contemplated by the terms of
the Transaction Documents, will be valid and binding obligations of the Company enforceable against the Company in accordance with their
terms except: (a) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo;
rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or
at law); (b) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities
laws; (c) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses
and to the discretion of the court before which any proceeding therefor may be brought; and (d) we have assumed the Exercise Price (as
defined in the Pre-Funded Warrants) will not be adjusted to an amount below the par value per share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The opinion contained herein is solely
for the information and may not be used, circulated, quoted, relied upon or otherwise referred to (a) for any purpose other than in connection
with the Registration Statement, the Base Prospectus and the Prospectus Supplement, or (b) any other person or entity. Our opinion is
rendered and is based upon the law and facts as of the date hereof, and we assume no obligation to update such opinion to reflect any
facts or circumstances that may hereafter come to our attention or any changes in the law that may thereafter occur.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">/s/ McLaughlin &amp; Stern LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">McLaughlin &amp; Stern LLP</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>ea025617901ex5-2_nexttech.htm
<DESCRIPTION>OPINION OF LONG REIMER WINEGAR LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><IMG SRC="ex5-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">September 3, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Univest Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">75 Rockefeller Plaza #1838</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The Purchasers listed on the Signature Pages to that
certain Securities Purchase Agreement, dated as of September 2, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>Next Technology Holding Inc.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">We have
acted as Wyoming counsel to Next Technology Holding Inc., f/k/a WeTrade Group Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection
with its Registration Statement on Form S-3 (File No. 333-267362) filed with the Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;)
on September 9, 2022 and declared effective on September 16, 2022 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;), pursuant to
the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;). On September 2, 2025, the Board of Directors
of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;) approved the Next Technology Holding Inc. offering and sale of up to 25,313,256
shares of Common Stock and prefunded warrants to purchase up to 34,686,744 shares of Common Stock (the &ldquo;<B><I>Prefunded Warrants</I>&rdquo;</B>)
of the Company (<B><I>&ldquo;The Offering&rdquo;</I></B>)<B><I>.</I></B> The Company offers the shares pursuant to the Company&rsquo;s
Registration Statement, base prospectus and a prospectus supplement to be filed on or about September 2, 2025 (together, the <B><I>&ldquo;Prospectus&rdquo;</I></B>)
under the Securities Act. This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5)
of Regulation S-K under the Securities Act in connection with the Registration Statement, and no opinion is expressed or may be implied
herein as to any matter pertaining to the contents of the Registration Statement other than as to the valid issuance of the shares of
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">As the
basis for the opinion hereinafter expressed, we have reviewed originals or copies of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-size: 10pt">A.</FONT></TD>
    <TD STYLE="text-align: justify">a copy of the Amended and Restated Articles of Incorporation of the Company, filed with the Secretary of State of Wyoming on March 29, 2023, as amended by the Certificate of Amendment filed on March 18, 2024, amending the name of the Company from WeTrade Group Inc. to Next Technology Holding Inc.</TD></TR>
  </TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border-top: black 1pt solid"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></TD>
    <TD STYLE="width: 21%; border-top: black 1pt solid"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></TD>
    <TD STYLE="width: 21%; border-top: black 1pt solid"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; border-top: black 1pt solid"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Office Address:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Mailing Address:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">T: 307.635.0710</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Cheyenne,  WY&middot; Jackson,  WY</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">2120 Carey Ave., Suite 300</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">P.O. Box 87</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">F: 307.635.0413</FONT></TD>
    <TD>C<FONT STYLE="font-size: 10pt; font-variant: small-caps">asper,  WY&middot; Evanston, WY</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Cheyenne, WY 82001</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Cheyenne, WY 82003</FONT></TD>
    <TD STYLE="text-transform: uppercase">w<FONT STYLE="font-size: 10pt; font-variant: normal">ww.lrw-law.com</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-variant: small-caps">Denver, CO &middot; Park City, </FONT> UT</TD></TR>
  </TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Next Technology Holding Inc.</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">September 3, 2025</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Page 2</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt"><FONT STYLE="font-size: 10pt">B.</FONT></TD>
    <TD STYLE="text-align: justify">a copy of the Second Amended Bylaws of the Company, effective as of March 29, 2023;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt"><FONT STYLE="font-style: normal; font-size: 10pt; font-weight: normal">C.</FONT></TD>
    <TD STYLE="text-align: justify">a copy of the Unanimous Written Consent of the Board of Directors In Lieu of a Special Meeting of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;) dated September 2, 2025 relating to, among other things, approval of the Offering and agreements related thereto, and authorization of ;</TD></TR>
  </TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">D.</TD>
    <TD STYLE="text-align: justify">the certificate of good standing covering the Company, issued by the Secretary of State of Wyoming as September 2, 2025 (the &ldquo;<B><I>Certificate of Good Standing</I></B>&rdquo;).</TD></TR>
  </TABLE>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">E.</TD><TD STYLE="text-align: justify">a copy of the Prospectus as described above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">We have
relied upon the foregoing and upon certificates and other assurances of officers of the Company and others as to factual matters without
having independently verified such factual matters. We have assumed for purposes of this opinion: (a) information contained in documents
reviewed by us is true, complete and correct; (b) the genuineness and authenticity of all signatures on original documents; (c) the accuracy
and completeness of all documents delivered to us and the authenticity of all documents submitted to us as originals; (d) the conformity
to originals of all documents submitted to us as copies; (e) the accuracy, completeness and authenticity of certificates of public officials;
(f) the legal capacity of all natural persons; and (g) the due authorization, execution and delivery of all documents by parties other
than the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">Where an
opinion is given &ldquo;to our knowledge&rdquo;, it refers only to the actual knowledge of the attorney signing the opinion, without any
inquiry or investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">We are
opining herein as to the Wyoming Business Corporations Act, as amended, and we express no opinion with respect to the applicability thereto,
or the effect thereon, of the laws of any other jurisdiction, or as to any matters of municipal law or the laws of any local agencies
within any state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Next Technology Holding Inc.</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">September 3, 2025</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Page 3</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">Based on
the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that:</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Company is a corporation validly existing and in good standing under the laws of the State of Wyoming,
with corporate power and authority to own, lease and operate its properties and to conduct its business as described in each of the Registration
Statement and the Prospectus and to enter into and perform its obligations under the transaction agreements with respect to the Offering;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the authorized, issued and outstanding capital stock of the Company conforms to
the descriptions thereof set forth or incorporated by reference in the Registration Statement and the Prospectus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">to our knowledge, no stockholder of the Company or any other person has any preemptive
right, right of first refusal or other similar right to subscribe for or purchase securities of the Company (or to act as a financial
advisor, underwriter or placement agent for such subscription or purchase) arising (a) by operation of the Amended and Restated Articles
of Incorporation of the Company, the Second Amended Bylaws of the Company and of the Wyoming Business Corporations Act, as amended, (b)
under any of the agreements and other instruments listed as exhibits to the Registration Statement, including those incorporated by reference,
pursuant to Item 601(b)(4) and (10) of Regulation S-K (the &ldquo;Applicable Agreements&rdquo;), except for such rights as have been duly
waived, or (c) to our knowledge, otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">to our knowledge, there are no legal or governmental actions, suits or proceedings
pending or threatened against the Company or any of its officers or directors (including in connection with the discharge of their duties
as officers or directors), or involving the assets, properties or businesses of the Company which are required to be disclosed in the
Registration Statement and the Prospectus other than those disclosed therein. We confirm to you that we are not representing the Company
in any pending or threatened litigation or governmental action in which the Company is a named defendant or target that challenges the
validity or enforceability of the transaction agreements with respect to the Offering and the Applicable Agreements, or seeks to enjoin
the performance of the transaction agreements with respect to the Offering and the Applicable Agreements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Next Technology Holding Inc.</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">September 3, 2025</P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">Page 4</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the statements in the Registration Statement and the Prospectus under the caption
&ldquo;Description of Securities We Are Offering&rdquo; and in the Registration Statement under the caption &ldquo;Description of Common
Stock&rdquo; insofar as such statements purport to describe certain provisions of documents referred to therein or matters of Wyoming law, fairly and accurately
describe in all material respects such legal matters and provisions described therein; and</TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">the Offering has been duly authorized, and when the Common Stock of the Company is issued in accordance
with the terms of the Offering, it will be validly issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">We expressly disavow any
obligation to advise you with respect to future changes in law or in our knowledge or as to any event or change of condition
occurring subsequent to the date of this letter. This opinion is for your benefit in connection with the Registration Statement and
may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Securities Act.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">We consent
to the filing of this opinion as Exhibit 5.1 to the Registration Statement. In giving these consents, we do not thereby admit that we
are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">LONG REIMER WINEGAR LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">/s/ GREGORY C. DYEKMAN</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">BY: GREGORY C. DYEKMAN</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">gdyekman@lrw-law.com</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ea025617901ex10-1_nexttech.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 2, 2025, BY AND AMONG THE COMPANY AND THE PURCHASER THERETO
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">SECURITIES PURCHASE AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This Securities
Purchase Agreement (this &#8220;<U>Agreement</U>&#8221;) is dated as of September 2, 2025, between Next Technology Holding Inc., f/k/a
WeTrade Group Inc., a Wyoming corporation (the &#8220;<U>Company</U>&#8221;), and each purchaser identified on the signature pages hereto
(each, including its successors and assigns, a &#8220;<U>Purchaser</U>&#8221; and collectively the &#8220;<U>Purchasers</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">WHEREAS, subject
to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as
defined below) as to the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares, the Company desires to issue and sell to each
Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully
described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy
of which are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE I.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">1.1&nbsp;
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">&#8220;<U>Acquiring Person</U>&#8221;
shall have the meaning ascribed to such term in Section 4.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Action</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Affiliate</U>&#8221; means any Person that, directly or
indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms
are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">&#8220;<U>Board of Directors</U>&#8221;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Business
Day</U>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Closing</U>&#8221;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Closing
Date</U>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to the Closing, (i) the Purchasers&#8217; obligations to pay the Subscription Amount
and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event
later than the first (1st) Trading Day following the date hereof (or the second (2<SUP>nd</SUP>) Trading Day following the date
hereof if this Agreement is signed on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight
(New York City time) on a Trading Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Closing
Statement</U>&#8221; means the Closing Statement in the form on <U>Annex A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 39pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Commission</U>&#8221;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Common Stock</U>&#8221; means the common stock of the Company,
no par value per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Common
Stock Equivalents</U>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Company
Counsel</U>&#8221; means McLaughlin &amp; Stern, LLP, with offices located at 260 Madison Ave., 18th Floor, New York, NY 10016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Company
PRC Counsel</U>&#8221; means Beijing Zhong Wen Law Firm, with offices located at 02/3/5/23F, Hexa International Plaza, No.9 Chaoyangmen
North Avenue, Dongcheng District, Beijing,100010, PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Disclosure
Time</U>&#8221; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Evaluation
Date</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Exchange Act</U>&#8221; means the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Exempt
Issuance</U>&#8221; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of
Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered
to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other
securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such
securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with
stock splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or
strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are
issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the prohibition period in Section 4.12(a) herein, and provided
that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the
Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>FCPA</U>&#8221;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>GAAP</U>&#8221; shall have the meaning ascribed to such term in
Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Indebtedness</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Intellectual
Property Rights</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Liens</U>&#8221;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Lock-Up
Agreement</U>&#8221; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors, officers, and
10% stockholders of the Company, in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Material
Adverse Effect</U>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Material
Permits</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Per Pre-Funded Warrant Purchase Price</U>&#8221;
equals $0.001, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Per
Share Purchase Price</U>&#8221; equals $0.15, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Person</U>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Placement
Agent</U>&#8221; means Univest Securities, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Pre-Funded
Warrants</U>&#8221; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, in the form of Exhibit A attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Pre-Funded
Warrant Shares</U>&#8221; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Proceeding</U>&#8221;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company&#8217;s knowledge, threatened against the Company before any court, governmental
agency or regulatory authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Prospectus</U>&#8221;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Prospectus Supplement</U>&#8221; means the supplement to
the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered by the Company to
each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Purchaser
Party</U>&#8221; shall have the meaning ascribed to such term in Section 4.9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Registration Statement</U>&#8221; means the
effective registration statement with Commission file No. 333-267362 which registers the sale of the Shares, the Pre-Funded Warrants
and the Pre-Funded Warrant Shares to the Purchasers, and includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Required
Approvals</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Rule
144</U>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or
interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same
purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Rule
424</U>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Rule
462(b) Registration Statement</U>&#8221; means any registration statement prepared by the Company registering additional Securities, which
was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by
the Commission pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>SEC Reports</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Securities</U>&#8221;
means the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Securities
Act</U>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Shares</U>&#8221;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Short
Sales</U>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Subscription
Amount</U>&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares and the Pre-Funded Warrants purchased hereunder
as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221;
in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 39pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Subsidiary</U>&#8221;
means any direct and indirect subsidiary of the Company, and shall, where applicable, also include any direct or indirect subsidiary of
the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Trading
Day</U>&#8221; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Trading
Market</U>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Limited Market, OTCQB, OTCQX or the OTCID(or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Transaction
Documents</U>&#8221; means this Agreement, the Pre-Funded Warrants, the Lock-Up Agreements, the Placement Agency Agreement and all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Transfer
Agent</U>&#8221; means Transhare Corporation with the address at Bayside Center 1,17755 US Highway 19 N, Suite 140, Clearwater FL 33764,
and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#8220;<U>Variable
Rate Transaction</U>&#8221; shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE II.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">2.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers,
severally and not jointly, agree to purchase, up to an aggregate of $9,000,000 of Shares set forth under the heading
&#8220;Subscription Amount&#8221; on each Purchaser&#8217;s signature page hereto, at the Per Share Purchase Price. Each
Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available
for &#8220;Delivery Versus Payment&#8221; settlement with the Company or its designee. The Company shall deliver to each Purchaser
its respective Shares and Pre- Funded Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall
deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set
forth in Sections 2.2 and 2.3, the Closing shall occur take place remotely by electronic transfer of the Closing documentation or
such other location as the parties shall mutually agree. Unless otherwise directed by the Placement Agent, settlement of the Shares
shall occur via &#8220;Delivery Versus Payment&#8221; (&#8220;<U>DVP</U>&#8221;) (i.e., on the Closing Date, the Company shall issue
the Shares registered in the Purchasers&#8217; names and addresses and released by the Transfer Agent directly to the account(s) at
the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically
deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by
wire transfer to the Company). Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of
this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the
&#8220;<U>Pre-Settlement Period</U>&#8221;), such Purchaser sells to any Person all, or any portion, of the Shares to be issued
hereunder to such Purchaser at the Closing (collectively, the &#8220;<U>Pre-Settlement Shares</U>&#8221;), such Purchaser shall,
automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally
bound to purchase, such Pre-Settlement Shares at the Closing; provided, that the Company shall not be required to deliver any
Pre-Settlement Shares to such Purchaser prior to the Company&#8217;s receipt of the purchase price of such Pre-Settlement Shares
hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a
representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any
shares of Common Stock to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be
made at the time such Purchaser elects to effect any such sale, if any. Notwithstanding anything to the contrary herein and a
Purchaser&#8217;s Subscription Amount set forth on the signature pages attached hereto, the number of Shares purchased by a
Purchaser (and its Affiliates) hereunder or as such Purchaser may otherwise choose, in lieu of purchasing shares of Common Stock,
Pre-Funded Warrants such Purchaser may elect to purchase in such manner to result in the full Subscription Amount being paid by such
Purchaser to the Company, shall not, when aggregated with all other shares of Common Stock owned by such Purchaser (and its
Affiliates) at such time, result in such Purchaser beneficially owning (as determined in accordance with Section 13(d) of the
Exchange Act) in excess of 9.99% of the then issued and outstanding Common Stock outstanding at the Closing immediately after giving
effect to the issuance of the Securities on the Closing Date (the &#8220;<U>Beneficial Ownership Maximum</U>&#8221;), and such
Purchaser shall, in lieu of purchasing Shares, purchase Pre-Funded Warrants in such manner to result in such Purchaser not exceeding
beneficial ownership of 9.99% and to result in the same aggregate purchase price being paid by such Purchaser to the Company.
Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded Warrants) delivered on or
prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of this
Agreement, the Company agrees to deliver the Pre-Funded Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for
purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 2.2 <U>Deliveries</U>.</P>



<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(a) On or
prior to the Closing Date (except as otherwise waived or indicated below), the Company shall deliver or cause to be delivered to
each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> (i) this Agreement duly executed by the Company;</P>



<P STYLE="text-align: justify; margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>legal opinions of Company Counsel, Company Wyoming Counsel and Company PRC Counsel, directed to the Placement Agent and the Purchasers,
in forms reasonably acceptable to the Placement Agent and the Purchasers;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>the Company shall have provided each Purchaser with the Company&#8217;s wire instructions, on Company letterhead and executed by
the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>a certificate executed by the Company&#8217;s Chief Financial Officer of the Company, dated as of the date of Closing, in form
and substance reasonable acceptable to the Purchasers and Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(v) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>a
secretary&#8217;s certificate executed by the secretary or an officer of the Company, dated as of the date of Closing, certifying to
the organizational documents of the Company, good standing in the jurisdiction of formation of the Company and board resolutions
authorizing the offering of the Shares, Pre- Funded Warrants and Pre-Funded Warrant Shares in form and substance reasonable
acceptable to the Purchasers and Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(vi) a certificate of
signed by the chief executive officer of the Company, dated, as applicable, as of the date of such Closing, to the effect that, as
of the date of this Agreement and as of the Closing Date, the representations and warranties of the Company contained herein were
and are accurate in all material respects, except for such changes as are contemplated by this Agreement and except as to
representations and warranties that were expressly limited to a state of facts existing at a time prior to the applicable Closing
Date, and that, as of the applicable date, the obligations to be performed by the Company hereunder on or prior thereto have been
fully performed in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt"> (vii) on the date hereof, the duly executed Lock-Up Agreements;</P>



<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT> the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(ix) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>for
each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to
purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&#8217;s Subscription Amount applicable to
Pre-Funded Warrants divided by the Per Pre-Funded Warrant Purchase Price, subject to adjustment as specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(b) On or
prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> (i) this Agreement duly executed by such Purchaser; and</P>



<P STYLE="text-align: justify; margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>such Purchaser&#8217;s Subscription Amount, which shall be made available for &#8220;Delivery Versus Payment&#8221; settlement
with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 2.3 <U>Closing Conditions</U>.</P>



<P STYLE="text-align: justify; margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent
representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(i) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects or, to the extent
representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(iii) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(iv) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>there
shall have been no Material Adverse Effect with respect to the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">(v) <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the
Company&#8217;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by
Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose
trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the
United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or
other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market
which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities
at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">REPRESENTATIONS
AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to
each Purchaser as of the date hereof (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports (as defined below<U>)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other
references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and, if applicable under the laws of the jurisdiction in which they are formed, in good standing under the laws of the
jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets
and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of
the provisions of its respective certificate or articles of incorporation, memorandum of association, articles of association,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects
or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on
the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any
of (i), (ii) or (iii), a &#8220;<U>Material Adverse Effect</U>&#8221;); provided that a change in market price or trading volume of
the Common Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse Effect, and no Proceeding has been
instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in
connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate
or articles of incorporation, memorandum of association, articles of association, bylaws or other organizational or charter
documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a
default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without
notice, lapse of time or both) of, any&nbsp;agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the
Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to
which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.5 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s)
to each applicable Trading Market for the listing of the Shares, or as applicable, Pre-Funded Warrant Shares, for trading thereon in the
time and manner required thereby, and (iv) such filings as are required to be made under applicable state securities laws, including the
filing of Form D with the Commission (collectively, the &#8220;<U>Required Approvals</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the
applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock
issuable pursuant to this Agreement a. The Company has prepared and filed the Registration Statement in conformity with the
requirements of the Securities Act, which became effective on September 16, 2022 (the &#8220;<U>Effective Date</U>&#8221;),
including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The
Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the
Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if
required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At
the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing
Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements
of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or
supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed
and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement
eligible to use Form S-3. The Company is eligible to use Form S- 3 under the Securities Act and it meets the transaction
requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve
(12) months prior to this offering, as set forth in General Instruction I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Capitalization</U>. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange
Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares
of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has
any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as a result of the purchase and sale of the Securities and set forth in the SEC Reports, there are
no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock or contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company or
any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding
securities or instruments of the Company with any provision that adjusts the exercise, conversion, exchange or reset price of such security
or instrument upon an issuance of securities by the Company. There are no outstanding securities or instruments of the Company that contain
any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is
or may become bound to redeem a security of the Company. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221;
plans or agreements or any similar plan or agreement. All of the outstanding capital stock of the Company are duly authorized, validly
issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws as applicable, and none
of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the
Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital
stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders except
for the Required Approvals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to
be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the
Prospectus and the Prospectus Supplement, being collectively referred to herein as the &#8220;<U>SEC Reports</U>&#8221;) on a timely
basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any
such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject
to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect
at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (&#8220;<U>GAAP</U>&#8221;), except as may be otherwise
specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all
footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements
included within the SEC Reports, except as disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no
event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company
has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary
course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the
Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or
made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing Company stock option plans. Except as disclosed in the SEC Reports, the
Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of
the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their
respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the
Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at
least one Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT> <U>Litigation</U>. Except as set forth in the SEC Reports , there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &#8220;<U>Action</U>&#8221;). None of the Actions set forth in the SEC Reports, (i) adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if
there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any
Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty, which could have or reasonably be expected to result in
a Material Adverse Effect. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation
by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any
stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the
Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#8217;s or its Subsidiaries&#8217;
employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state,
local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and
hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all applicable foreign, federal, state and local laws relating to taxes, environmental protection,
occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &#8220;<U>Hazardous Materials</U>&#8221;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#8220;<U>Environmental Laws</U>&#8221;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such certificates, authorizations or permits could not reasonably be expected to result
in a Material Adverse Effect (&#8220;<U>Material Permits</U>&#8221;), and neither the Company nor any Subsidiary has received any notice
of proceedings relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material
respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and
similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and
which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<U>Intellectual Property
Rights</U>&#8221;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of,
the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the
SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the
knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another
Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged,
including, but not limited to, commercially reasonable directors and officers insurance coverage. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(r) <U>Transactions
With Affiliates and Employees</U>. Except as disclosed in the SEC Reports, none of the officers or directors of the Company or any
Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of
$120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on
behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the
Sarbanes- Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date in all material respects. Except as
disclosed in the SEC Reports, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Except as disclosed in the SEC Reports, the Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. The
Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<U>Evaluation
Date</U>&#8221;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Certain Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&#8217;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. Other than for Persons engaged
by any Purchaser, if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on
behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Registration Rights</U>. Except as disclosed in the SEC Reports, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT> <U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice
from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. Except as disclosed in the SEC Reports, the Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the
Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their
agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not
otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing
representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company
to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, is
true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT> <U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of any
Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(aa) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the
business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. The SEC Reports disclosed, as of the date thereof, all outstanding secured and unsecured Indebtedness
of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &#8220;<U>Indebtedness</U>&#8221;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties by
endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the
present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(bb) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect, the Company and its Subsidiaries each (i) has made or filed all applicable United States federal, state and local income and
all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any
material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary
know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(cc) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(dd) <U>Accountants</U>.
The Company&#8217;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm
(i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial
statements to be included in the Company&#8217;s Annual Report for the fiscal year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ee) <U>Acknowledgment
Regarding Purchasers&#8217; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&#8217; purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ff) <U>Acknowledgment
Regarding Purchaser&#8217;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the
Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including,
without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities; (iii) any
Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv) each Purchaser shall not be deemed to
have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction. The
Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times
during the period that the Securities are outstanding, and (z) such hedging activities (if any) could reduce the value of the
existing stockholders&#8217; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(gg) <U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(hh)&#9;<U>[Reserved]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Cybersecurity</U>.
(i)(x) To the Company&#8217;s knowledge, there has been no security breach or other compromise of or relating to any of the
Company&#8217;s or any Subsidiary&#8217;s information technology and computer systems, networks, hardware, software, data (including
the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it),
equipment or technology (collectively, &#8220;<U>IT Systems and Data</U>&#8221;) and (y) the Company and the Subsidiaries have not
been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data, except as would not, individually or in the aggregate for all such matters referred
to in this clause (i), have a Material Adverse Effect; (ii) the Company and the Subsidiaries are presently in compliance with all
applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or
regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and
to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not,
individually or in the aggregate, have a Material Adverse Effect; (iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>the
Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the
Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with commercially reasonable
industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(jj)&#9;<U>Compliance
with Data Privacy Laws</U>.&#9;To the Company&#8217;s knowledge, (i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>
the Company and the Subsidiaries are, and at all times during the last three (3) years were, in compliance with all applicable
state, federal and foreign data privacy and security laws and regulations, including, without limitation, the European Union General
Data Protection Regulation (&#8220;<U>GDPR</U>&#8221;) (EU 2016/679) (collectively, &#8220;<U>Privacy Laws</U>&#8221;); (ii) the
Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance with
their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and
analysis of Personal Data (as defined below) (the &#8220;<U>Policies</U>&#8221;); (iii) the Company provides accurate notice of its
applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv)
applicable Policies provide accurate and sufficient notice of the Company&#8217;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&#8217;s then-current privacy practices, as required by
Privacy Laws. &#8220;<U>Personal Data</U>&#8221; means (i) a natural person&#8217;s name, street address, telephone number, email
address, photograph, social security number, bank information, or customer or account number; (ii) any information which would
qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as amended; (iii)
&#8220;personal data&#8221; as defined by GDPR; and (iv) any other piece of information that allows the identification of such
natural person, or his or her family, or permits the collection or analysis of any identifiable data related to an identified
person&#8217;s health or sexual orientation. (i) None of such disclosures made or contained in any of the Policies have been
inaccurate, misleading, or deceptive in violation of any Privacy Laws, except as would not, individually or in the aggregate for all
such matters referred to in this clause (i), have a Material Adverse Effect and (ii) the execution, delivery and performance of the
Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries, to the
knowledge of the Company, (i) has received written notice of any actual or potential liability of the Company or the Subsidiaries
under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently conducting
or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request or
demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or
governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(kk) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with
the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ll) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&#8220;<U>OFAC</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(mm) <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(nn) <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &#8220;<U>BHCA</U>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<U>Federal
Reserve</U>&#8221;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(oo) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<U>Money Laundering Laws</U>&#8221;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized
by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it
in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT><U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is an &#8220;accredited
investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities
nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the
material pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with
respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered
by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without
limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained
the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).
Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or
preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>No Voting Agreements</U>. The Purchaser is not a party to any agreement or arrangement, whether written or oral, between the
Purchaser and any other Purchaser and any of the Company&#8217;s stockholders as of the date hereof, regulating the management of the
Company, the stockholders&#8217; rights in the Company, the transfer of shares of Common Stock in the Company, including any voting agreements,
stockholder agreements or any other similar agreement even if its title is different or has any other relations or agreements with any
of the Company&#8217;s stockholders, directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Brokers</U>. Except as set forth in the Prospectus Supplement, no agent, broker, investment banker, person or firm acting in
a similar capacity on behalf of or under the authority of the Purchaser is or will be entitled to any broker&#8217;s or finder&#8217;s
fee or any other commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could
have any liabilities in connection with this Agreement, any of the transactions contemplated by this Agreement, or on account of any action
taken by the Purchaser in connection with the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Independent Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on
behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely
on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in
any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or
the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, except as set forth in this Agreement, with
respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE IV.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">OTHER AGREEMENTS
OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Shares</U>. The Shares and Pre-Funded Warrant Shares shall be issued without restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Pre-Funded Warrants</U>. If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective registration
statement to cover the issuance or resale of the Pre-Funded Warrant Shares or if the Pre-Funded Warrant is exercised via cashless exercise,
the Pre-Funded Warrant Shares issued pursuant to any such exercise shall be issued free of all restrictive legends. If at any time following
the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Pre-Funded
Warrant Shares) is not effective or is not otherwise available for the initial sale by the Company, or the resale by the Purchasers, of
the Pre-Funded Warrant Shares, the Company shall immediately notify the holders of the Pre-Funded Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and
available for the initial sale by the Company or the resale by the Purchasers of the Pre-Funded Warrant Shares (it being understood and
agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Pre-Funded Warrant
Shares in compliance with applicable federal and state securities laws). The Company shall use commercially reasonable efforts to keep
a registration statement (including the Registration Statement) registering the issuance or resale of the Pre-Funded Warrant Shares effective
during the term of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Furnishing of Information</U>. Until the earliest of the time that (i) no Purchaser owns any Shares, or (ii) the
Pre-Funded Warrants have expired the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is
not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other
transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of
the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the
Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of
the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or
agents, including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all
confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or
any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, on
the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or
effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press
releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press
release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of
any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall
not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall
promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the
Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the
Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required
by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent
such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior
notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such
disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.6<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Stockholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an &#8220;<U>Acquiring Person</U>&#8221; under any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted
by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.7<FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT><U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.5, the Company covenants and agrees that neither it, nor any other Person
acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in
writing to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company
understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of
the Company. To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the
Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its
Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of, such material, non-public
information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to
any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the
Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current Report on
Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.8<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes
and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&#8217;s debt (other than payment of trade payables
in the ordinary course of the Company&#8217;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock
Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.9<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.9, the Company will indemnify and hold each Purchaser and its
directors, officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such
Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
stockholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;Purchaser
Party&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation
that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action
instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the
Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is solely based upon a material breach of such Purchaser Party&#8217;s representations, warranties or
covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party
which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own
choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such
Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of counsel a material conflict on any material issue between the position of the Company and the
position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by
a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed;
or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s
breach of any of the representations made by a Purchaser Party in this Agreement or the other Transaction Documents. The
indemnification required by this Section 4.9 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the
Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.10<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and
keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the
Company to issue Shares pursuant to this Agreement and Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.11<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Pre-Funded Warrant Shares on such Trading Market and promptly secure the listing of all of the
Shares and Pre-Funded Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock
traded on any other Trading Market, it will then include in such application all of the Shares and Pre-Funded Warrant Shares, and will
take such other action as is necessary to cause all of the Shares and Pre-Funded Warrant Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
Common Stock on a Trading Market and will comply in all material respects with the Company&#8217;s reporting, filing and other obligations
under the bylaws or rules of the Trading Market. The Company agrees to use commercially reasonable efforts to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 4.12 <U>Subsequent Equity Sales</U>.</P>



<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>From
the date hereof until 60 days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement, the filing of any
amendment or supplement to an existing registration statement for an &#8220;at the market&#8221; offering with the Placement Agent
as sales agent, or filing a registration statement on Form S-8 in connection with any employee benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>From the date hereof until 60 days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &#8220;<U>Variable Rate Transaction</U>&#8221; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such
debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &#8220;at-the-market offering&#8221;, whereby the Company may issue securities
at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether
such agreement is subsequently canceled ; <U>provided</U>, <U>however</U>, that, after 30 days after the Closing Date, the entry into
and/or issuance of shares of Common Stock in an &#8220;at the market&#8221; offering with the Placement Agent as sales agent shall not
be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any
such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate
Transaction shall be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.13<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the
Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.14<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.5. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.5, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information
(other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything
contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any
representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after
the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.5, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of
the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in Section 4.5 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its
Subsidiaries, or any of their respective officers, directors, employees, Affiliates, or agent, including, without limitation, the
Placement Agent, after the issuance of the initial press release as described in Section 4.5. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such
Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.15<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Capital Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward
stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest
of the Shares other than a reverse stock split that is required, in the good faith determination of the Board of Directors, to maintain
the listing of the Common Stock on the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.16<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Lock-Up Agreements</U>. Without the prior written consent of the Placement Agent, the Company shall not amend, modify, waive
or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions
of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement,
the Company shall promptly use its commercially reasonable efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.17<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Pre-Funded Warrants Exercise Procedures</U>. The forms of Notice of Exercise included in the Pre-Funded Warrants set forth
the totality of the procedures required of the Purchasers in order to exercise the Pre-Funded Warrants. No additional legal opinion,
other information or instructions shall be required of the Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding
sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise form be required in order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded
Warrants and shall deliver Pre-Funded Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties,
if the Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise
notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to
be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and the
Pre-Funded Warrant Shares initially issuable upon exercise of the Pre-Funded Warrants based on the initial Subscription Amounts
hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom
enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted Purchaser (or at least 50.1%
in interest of such multiple Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially
and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other
Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.6<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.7<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.8<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations, warranties,
and covenants of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement.
This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.9 and this Section
5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.9<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be
governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or
Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is
improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under
Section 4.9, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or
Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.10<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.11<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &#8220;.pdf&#8221; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.12<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.13<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; provided, however, that, in the case of a rescission of an exercise
of a Pre-Funded Warrant, the applicable Purchaser shall be required to return any Pre-Funded Warrant Shares subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Pre-Funded Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.14<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT><U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in
lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.15<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.16<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.17<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Independent Nature of Purchasers&#8217; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in
any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers
as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood
and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.18<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT> <U>Liquidated Damages</U>. The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under
the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages
and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.19<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.20<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT><U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">5.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT></FONT><FONT STYLE="text-decoration: underline solid">WAIVER OF JURY TRIAL</FONT>. <FONT STYLE="text-decoration: underline solid">IN
ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY,
TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL
BY JURY.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="3"><B>Next Technology Holding Inc.</B></TD>
    <TD>&nbsp;</TD>
  <TD><U>Address for Notice:</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD><U>Email</U>:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 5%">Name:&nbsp;</TD>
  <TD STYLE="width: 30%">Wei Hong Liu</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 56%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive
Officer</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="3">With a copy to (which shall not
constitute notice):</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK <BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[PURCHASER SIGNATURE PAGES
TO NXTT SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Purchaser: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
    </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Purchaser</I>:</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Address for Delivery of Securities
to Purchaser (if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Subscription Amount: $&nbsp;<U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Shares: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Pre-Funded Warrants: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">Pre-Funded Warrant Shares: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">EIN Number: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify">Notwithstanding anything contained in this Agreement to the
contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased
from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional
and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the second (2nd) Trading Day following the date of
this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above)
that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as
applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable)
to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea025617901ex99-1_nexttech.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><I><IMG SRC="ex99-1_001.jpg" ALT=""></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Source:</I></B><I> Next Technology Holding Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>September
02, 2025 13:30 ET</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt"><B>Next Technology Holding Inc. Announces $9 Million Registered Direct
Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">CHEYENNE, WY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (NASDAQ: NXTT) (the &ldquo;Company&rdquo;), today announced
that it has entered into a definitive agreement with one investor for the purchase and sale of an aggregate of 60,000,000 of the Company&rsquo;s
common stock, no par value (the &ldquo;Shares&rdquo;) (or pre-funded warrants in lieu thereof) at a purchase price of $0.15 per share
in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the
exercise price of $0.001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The aggregate gross proceeds to the Company of this offering are expected to be approximately $9 million. The transaction is expected
to close on or about September 3, 2025, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Univest Securities, LLC is acting as the sole placement agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The registered direct offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-267362) previously filed
by the Company and declared effective by the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 16, 2022. A final
prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be
available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying
prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This press release does not constitute an
offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which
such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such
jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base
prospectus will be filed by the Company and, upon filing, can be obtained at the SEC's website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>About Next Technology Holding Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Incorporated in Wyoming on March 28, 2019, Next Technology Holding Inc. is a technology company built on a dual-engine strategy of &ldquo;AI
plus digital assets.&rdquo; The Company delivers AI-enabled SaaS software design, development and implementation to industrial clients
across the Asia-Pacific region and beyond. Holdings may also be pledged for financing, partially liquidated for cash, or leveraged to
generate additional income streams. The Company believes Bitcoin&rsquo;s finite supply positions it for long-term appreciation as global
adoption grows and as a potential hedge against inflation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For more information, please visit http://www.nxtttech.com/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks
and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes
may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking
statements by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;is/are likely to&rdquo; or other similar expressions. The Company undertakes no obligation to update forward-looking statements
to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the
Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations
will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results
and encourages investors to review other factors that may affect its future results in the Company&rsquo;s registration statement and
in its other filings with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>For investor inquiries, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">ir@nxtttech.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>For general inquiries, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">contact@nxtttech.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !8 /$# 2(  A$! Q$!_\0
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M@O?_ /@0_P#C6?D9QGFC(SCO3T)NS1_M[6?^@O?_ /@2_P#C2#7M9_Z"U_\
M^!#_ .-4**+"NSZ"^ M[=WND:RUW=3W!6X0*99"Y'R]LUZZ:\<_9[_Y NM_]
M?*?^@U[)7)4^)GH4O@1X-\5+F\MOBII,$%_=Q07*0^9'',RJ?GQT!]!7O
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M,^I85\HU])?'2XDA\ K$@.V:[C5R/09/-?-M=-+X3AQ#]X]\_9[_ .0+K?\
MU\I_Z#7LAKQO]GO_ ) NM_\ 7RG_ *#7L9K&I\3.FE\"/!_BI<WUO\4=,M8-
M1O(;>[2'S(XIF0<OM/0^E=1XY\(MH/A>\UG0]9U:UN[)?-^:\=U=<\@@UR'Q
MA:1/BIH;Q1^9(L415,XW'S#QGM6E\2O'6J2P1^%]2TAM%CU J)KJ643 1;N2
M-OZU=F[6,VU>5SL_A1XKOO%GA)KC42KW=M.8'D QY@ !!^O->>^/);P?&>TT
MU-1O8K.\:#S(HIV0 -P<8/'2O7/!OAG3_"GAR#3M/<RQ']ZTQZRLW\7\OPKQ
M[XD"X/QPTP6C1K<D6_E-*"5#9.,@=J4;.3L5.ZBKGI.H?#.RN+5X[36=:M9_
MX)1>N^#[@GD4GQ1,]G\,K^6&YEBN+=8BLL3E6SN SD>N35R.#QXNH69GO=%>
MS$H^TK#"ZN4[X))YJM\7/^28:S_NQ_\ HQ:A;HM_"RC\&)+BY\!B[N[J:XFF
MN9,O*Y8@#  YKSKXBZOJWASXE7-[IEY>?8[:2&22+SF,8=ADKCT.#Q7HGP2_
MY)O;_P#7Q+_.J%_X=3Q5XA\?:<0I:2&U$3'^&55)']/SJU92=R&FX*QZ/I&I
MP:SI-KJ5LP:"YB61/Q'2O,OC7XDOK+3X=*TJ:6*7 N;N6%BICCW;5&1TRQ_2
MJ?P2\3F#3]1\-ZDYCET\M,@?^% ?G'X'^=1>)(GU'X8^)O%-PI$NK31F -U2
MW1PL8_'D_C22M(<I<T-#L_A)+-<?#K3[BXGEGFE>0O)*Y9C\Y'4^PKSFZ^U:
MA\=[C1)=2U!=/DG.8HKEDQ\F[C!XYKO_ (,2F7X9V (QLEE4?]]D_P!:\XO5
MOW_:'G739(([SS_W;7"ED'[OG('--?$R7\,3TZ^^&MK)&IL-:UFUN$8,KF\=
MU.#G!!/2J/QGDN;3P#]JM;J:WGBN8_GB<J2#D$<5NV,/C9-9M3J-YI$FG?-Y
MRVT3J_3C&XGO6%\;O^2;S_\ 7S%_,U*^)%R^%F=X#\)6_B3P'8:C>ZGJXO;A
M6W2QWKC!#$ @9QVK,^&_B[7(/']YX1U6^DU"!&E2*:4Y=2G/7T(J/PQXVU?P
MG\*+*Z3PY)<6<2LJ7?VA=N2QP2O4#/%:OP?\/V%U'/XRDO1>:K>NXD4+@6Q)
MRRX]??TJGUN0M6K'K0Z4445D= 4444 %%%% !110: "C-<UXL\;Z+X/LS+J-
MP#.PS%;1G,DGX=A[FO(_#WQAO;WXB1W6J.+?2+A?LX@!RL.3\K$^N>IJE!M7
M,Y5(Q=F?0-5;[4+33;5[J]N8K>!!EI)&"@5B>-/&%IX/\.R:G+B61OEMX@W^
MM<]/P[DU\N^(O%6L^*KUKG5;QY1G*0@XCC]@M5"#D34JJ)VWQ8^(UIXL\C2M
M)WM86\GF/,PQYK=!@>@KS"BCI75&*BK(XI2<G=GOG[/@/]B:TV#@W* '_@->
MR&N ^#VAOHO@&U:92L]ZQN6!Z@'[OZ#]:[^N.;O)G?35HI'A'Q1L-1O/BEI5
MS;:;>36]JL(>6*%F7[^3R/2O2?'W@NV\;: UJ2L=Y%^\M9B/NMZ'V/>NMHHY
MMO(?(M?,\E^'&NZ[X=G7PEXIT^[C$9VV=WL+)C^Z6';T-<_X[MM0?XS6FJ1Z
M7?365FT&^6&!G!"\G&!SUKWJBGS:W$Z>EKG#ZE\2+>VM)'LM"UN[N,?)']B9
M 3[D]!5;Q^=1U/X13B2SD;4;N*$M;P(6*L65B,=>,5Z#U[TG&:E.Q3BWNSSS
MX,PW5IX$%G>VD]M-#<R929"I(."#S5OPCYW_  G?C)Y+6>*.2>(Q2.A"R )@
ME3WYKN<9ZT<4-[@HV278\+\9> =3/Q1MY=&2:*SU@$7,L0.V,'B0$]@1_.NZ
M^)M@1\,KS3K"UDE(6**&&%"QP&&, >PKNJ,4^9Z>1/(M?,\^^#4-U:> TM+R
MTFMIH;B0%)4*D@G(.#]:X.ZCO=/^.T^N2:5J$FGQSG,L5LSY^3;D8Z\U[[13
MYM6P<-$NQPFK?$E;>T;^S/#^LWET>$1K-D4'U)/:J/Q=BO[[X=16T5I+<7LT
MT1>.!"V"!EN!VS7I-' I)VU0W%M--G!_#?2UN/A;9Z5JEFZ!DDBG@G0J<%CV
M/UKA+'2?$?PC\5RS6MG<:EX<NFP_D*6(7L2!T8?K7N]%"EN)PT7D06-Y#J%E
M%=VY8Q2J&7<I!Q[@]*L4@I:DT"BBDR* %HHHH #7EGCWXPV&@>?INB[;O5%)
M1G(_=P'W]3[5ZG7!^-_A;I'B\/=1@66IXXN(UX?_ 'QW^O6JC:^I$^:WNGS)
M?W]WJM]+>WUP]Q<RMN>1SDG_ .M5:MWQ-X1UGPE>FWU6U**3^[G3F.0>Q_I6
M%78K6T/.E=/4FFN[FY2-+BYFE2(;8UD<L$'H,]*AHIT<;S2K%$C/(YPJ*,EC
MZ 4Q:L;7=?#3P%/XPUI)[B)DTBV<-/(1@2$?P+_6NG\$?!.YOO+O_$Y:VM^&
M6S0_.X_VC_"/;K7NMAI]IIEE%9V5O'!;1#"1QC  K"=1;(Z:=%[R)XT6.-41
M0J*  HZ >E*Z[E(/0C%.HKG.P\'TW5M7\)?&I=&U35;RXTZ:0I")Y2R[9!\A
M_ \5M_&M=:TNUL==TG4KNWB1_)N(XI2J\\JQ'YC\JJ_'C0W%KIOB6U!6:UD$
M,CKV!.5/X'^=;7B'78?$_P (;=XX5N+S5TCM88L\^>3@_D036O9G/WB2?#J[
MOO%&JZAXIFN;I=/94M[2V9SLW*H#OCZ_UJ;66O-;^*^FZ5:WUS!9:?:FZO4A
MD*AR6^16Q]*YOX'ZZUK;ZMX9OV\N2P=ID#'&U<X<?@1G\:Z[X=0O?1ZMXFG4
M^9J]VSQ9ZB%/E0?3@FE+1LJ+NDCA_C7JFJZ3XDT@:?JEW:1W$!#I#*5'#8SC
MUYKU#Q+:-)X+O46ZN(9(K0R)-%(5<,JY!S^%>3?'S_D8O#__ %Q;_P!#%>Q>
M(/\ D4=3_P"O&3_T T/9 OBD>(> /B+J_AW7(K#Q3<W$MA?HKQS7#%C'N^ZP
M/]T]Z]YU(>?H]T(Y&7= Y62-L$?*<$&O-;KP)!XT^$VB+&%34[>R5K:4]^/N
M'V/Z5C_#7QW/;6]WX-\0EHKN".2.U>7@Y /[LY[^E-I/5"BW'21Z!\,6NI_A
M[I=Q>W4MS<7"-(\DKEF.2>,UY7X-DU3Q#\2]2T6^UW519PM.46*Z92-K8'->
MK_#+_DFVA?\ 7O\ U->/>!3J8^,&L?V2MJUSNN.+HL$QOY^[SFA=0E]D]9'@
M2XM=5L;ZQ\2:N$@F#RV]S<&1)5[CVJM\3?B!_P (5I<4=HB2ZG=Y\E7Y5%'5
MB._L*V-+E\7G7-FKP:8NF^42'M'8MO[ [NW6O&?C.S/\3K!)\^0(8,9Z8+G-
M3%7>HYOECH>@>&_ VH:UID&J^+-;U2XO;E1(+>&X:&.%3R!A<<U?3P'J.D:[
M8WNA^(M02S68&[LKJ8RJZ=]I/>NYA"B% OW0HQ],5RNO_$+2O#OB*UT2\M[M
MKJZV>48X\JVXX'.?6E=MZ%<L4M3K:\0^,'C/5K/6[>UT:XGA@TUD:[EB;"F5
M^51OP!X]Z]@UK58-$T6[U.Y8"*VB:1L]\#@?B>*\9BO/#^I_#+5+?4M17^W-
M5=[Z7,3DK+G*+G'8 "G#NQ5'I8]DT#5HM<T*QU.$@I<PK)QV)'(_/->;_'/4
MM0TG2M)N=.O[FTD>=T8PR%=PVYY_*J_P%\0?:='O-!F8B6T?SHE/]QNH_ _S
MI/V@_P#D7]'_ .OI_P#T TU&T["E*].YMZ7X-N=3\(V5];^)=<@U&>T659/M
M990Y7/W3VS67\)/'FKZYJ5]H.N2BXN+92\=Q@ D*VTAL=?K4=Q\1;_PK\.]+
M=O#MVC26J0P7+R+Y9;;PW!S[XK5^$?A"RTG2#KZWJWUYJ:!FE48"*3DJ/?/7
MZ4/9W$OB7*>E<448HK,W%HHHH J:CIEEJUE)9W]M%<6\@PT<BY!KPKQO\$[F
MP\R_\,%[FW'S-9L<R)_NG^(>W6BBJC)IZ&<X*2U.&\+^ M>\5WQM[.T:&*-]
MDUQ.I5(B.H/J?85]#>#/AMHG@^)98H_M6H$?/=S+D_\  1_"***NI-MV,Z4(
MVN=EBEHHK(Z HHHH R/$VC1^(/#E_I<@&+F%E4GLW8_GBO(?@UHFK2ZG(NII
M(EEHTLA@BD4C]^_RDC/7 !_.BBKB_=9E)>\F5?B#X:U;2_B?%=:&DB+KB&)G
MC4D*7^60'TX.:]TTS3X=*TNUL(!B*VB6)![ 8HHHD[I#A%)L\1^.R37'B;1D
M@MYI?)@+.4C+ 9<8Z?0UZYXBN$7P1J4X#,K6#E0!R<IQQ^-%%-[(F/Q2*WP^
M?S/ &B?*RE;55*L,$$<'BN,^+GP[;6;9O$.CQ$:I;KF9(^#,@[C_ &A^HHHI
M7M+0II2AJ=;\-5:+X<:&LBLC+;?,&&".37CW@748=$^*VJ:IJ23P6<C7 64P
M.P)+<=!1151W9G/11/4-1^)^G"YM[+1;2[U&[N)5C0B!TC3)P2S$=JSOBWX
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61[!_PD&D_P#00M_^^Z***?(@]HS_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $L 2P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#P?>W]YOSH
MWM_>;\Z2BO4)%WM_>;\Z-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=[?WF_.C>W
M]YOSI** %WM_>;\Z-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=[?WF_.C>W]YOS
MI** %WM_>;\Z-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=[?WF_.C>W]YOSI**
M%WM_>;\Z-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=[?WF_.C>W]YOSI** %WM_
M>;\Z-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=[?WF_.C>W]YOSI** %WM_>;\Z
M-[?WF_.DHH 7>W]YOSHWM_>;\Z2B@!=S?WF_.I$9L?>;KZU%4B]*0$=%%%,
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MQE NW/L-Q./IZ5[=WKQ+]I"/.@:'+_=NI%_-/_K5PT_C11\ZT445Z)(4444
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M<>-0O4&Q6',4)Y ^K<$^V!ZUZ #4)?AG8@ #+,3@ >I]*X?Q'\5-&T?S(--
MU.['&4;$*GW;^+_@/YUR:R8SOGD2*)Y9'6.-!EW=@JJ/4D\"O/\ Q'\7=*TS
M?;Z.@U*Z''FDE8%/UZM^&![UY/K_ (NUGQ-)_P 3&[8P@Y2WC^6)/HO<^YR:
MP:UC2[@;.O>*-8\1W FU.^>4 Y6(?+&G^ZHX'UZUC445LDEL(****8!1110
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MD?;=W/EVH.5M8?EC'U'\1]SFN=HHII); %%%%, HHHH **** "BBB@ HHHH
M**** "I$^[^-1U(GW?QH CHHHH **** "BBB@ HHHH **** "O3O@YX"_P"$
MM\0?VE?1;M(TYP74CB:7JJ>X'4^V!WKA?#^AWGB37+72+",O<7+[0>R#NQ]@
M,D_2OLKPSX>L_"WA^TTBQ7$4"8+$8,C?Q,?<GFN:M/E5D-&U1117(,*2EKA?
M%_Q5\-^$%>&>X^UZ@/\ ESMB&8'_ &CT7\>?:A)O1 =UFO/?&'Q>\-^%/,@6
M;^TM07C[-:L"%/\ MOT7Z<GVKPGQA\7O$GBSS(%F_L[3VX^S6K$%A_MOU;Z<
M#VKS^NB%!_:%<[CQ?\5/$OB]GAGN?LFGMTL[8E5(_P!H]6_'CVKAZ**ZE%)6
M0@HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J1/N_C4=2)]W\:
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MJ--1V$%%%%6 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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@R%]6_.CR%]6_.BX%>I$^[^-2>0OJWYU(MNF.K47 _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>nxtt-20250902.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qRZo7xRiXhun8uNbXQsSaiI2aPtypR1OYkxs2t5HVm6fyEicsFRei9nbjv2gT4P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:NXTT="http://nxtttech.com/20250902" elementFormDefault="qualified" targetNamespace="http://nxtttech.com/20250902">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://nxtttech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="nxtt-20250902_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="nxtt-20250902_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>nxtt-20250902_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>nxtt-20250902_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="nxtt-20250902.xsd#Cover" roleURI="http://nxtttech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nxtttech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEXT TECHNOLOGY HOLDING INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001784970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-4948289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Room 519, 05/F Block T3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Qianhai Premier Finance Centre Unit 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Guiwan
Area, Nanshan District<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Shenzhen<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">518000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">7421477289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NXTT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0256179-8k_nexttech.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nxtttech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0256179-8k_nexttech.htm">ea0256179-8k_nexttech.htm</File>
    <File>nxtt-20250902.xsd</File>
    <File>nxtt-20250902_lab.xml</File>
    <File>nxtt-20250902_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0256179-8k_nexttech.htm": {
   "nsprefix": "NXTT",
   "nsuri": "http://nxtttech.com/20250902",
   "dts": {
    "inline": {
     "local": [
      "ea0256179-8k_nexttech.htm"
     ]
    },
    "schema": {
     "local": [
      "nxtt-20250902.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "nxtt-20250902_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nxtt-20250902_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://nxtttech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0256179-8k_nexttech.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0256179-8k_nexttech.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nxtttech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-25-085190-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-085190-xbrl.zip
M4$L#!!0    ( "R1)5MN:]<@*2$  /*J   9    96$P,C4V,3<Y+3AK7VYE
M>'1T96-H+FAT;>T]:5?;R++?]2OZ^=ZY ^?:QO("&!+N 6,""0&"G4EFOG#:
M4MM6D"5'+6$[O_Y5]:+-,EL@RV3FS$QBJ9?JZMJKNO7B?_.)2VY8P!W?>_F[
M6:W]3IAG^;;CC5[^OM_KG)S\_K\]X\4XA&;0U.,O2^,PG.YL;,QFL^JL4?6#
MT8;9;K<WYMBF)!OMS O;U6LU<^/CV].>-6836G$\'E+/8G$GU_&N5X^/;^.F
M@\!U,DWQB9ZDL;$T-+RUDP[IQIL;\F6F:5C8M"6;AKJIP_UFW=RZ#0[9(NXP
M7]761)AAA>SCP>5ITCPL;I\TW0@#ZO&A'TQH"%N(([4JM7JEOID:I,*9E1D(
M?E='_LV=XVQ7&J8>9VESLBO%UP/*8XS;+(=N/2>\@![UEFX8\<J(TFG<>$CY
M0 RK7N0;![[+>&%K\2;3W/(C+PP6Q8"HEYD./ B7AX:'F49G'_O]N)4W#\.0
M6>.JY4]$JUJ[5B\ARS!J[QD$_WD1.J'+]EYLR#^-%Q,64H(#5-CGR+EY6>KX
M7LB\L-)?3 &#EOSULA2R>;@A^&H#>FW((5_\7Z5"CASFVCNDQ\)=<D8G;(?,
M[?DN.3D4?[FJU;M7[WN_U0]?[>]?P!\(&*E4[MFYT;W"-5ZEUW:EUW;_89K[
M<:=']&ZUKQC0"@ /_^Y/F&?#?^&12T=70^IR]H"1FJF1NAYLPJ(#0P74/?%L
M-G_#%E<UD$Q;V\WV5NW^PVX> (H/K\PKQ>1R?'CT@"'J5[TQ#1B_JE\)D2;'
MX.+9 X8Y1$@NU%"-)8!6C3WP[07AX<)E+TM#H+D=8M:F(>D[$VAQQF;DTI]0
MKRP?E&'^P!DB:=O.C>YF.WSJTL4.\7R/X3MGOH-DR@*@??'#L6WF(2/@+VAU
M%DU@'$L2^3R\9,.7I7U^/D0*J=3:(+Q*Q+%?EHZH%=;PGT:)>+!HF(LY.QE"
M*.T)2GBQD1GY:^9JIN<J))727D(K11-OI->,8 1LR +0J8R+]R@G=[A0@  .
M$5IM9QP@9,AN%<THU3FW2^IU"%+A98D[DZG+4!*H:3(CRZFX'P5J)F@DMGU'
M+5XL-+=X)9]T2R86K!_&CQT;7PP=%A !."O4)9V3-UG<Y#O'DVT4S:;FF@(B
M?7L)!-#F07A(0[:70*_'2=[E>P&IK.BCW^1 2L^NGRGT95 :>8[$)S!7'HD3
M1GD4L#W%A#O01 ^E7V7&Q[&*!Y?\O&I\M7C1YI$3)$(C/PEP.&S<$D*QIR!V
M&OI!\O;!:\^#5S!F:L9#YOD3Q[MCSCOQD9^T8%C].KW\/!H5ZR6<)EE>R;P7
M&]!WSS",%].'2M9=,J'!R/%V"#:ME<!>F,)(:0UP&;FL<D%'0OFEQ;#L60G]
MJ>BMAZH,_##T)^K9S+'#,4)2^ZV4Z3WP P!>]CYPJ75-Z@ !]UW'WB7JI1Y)
MOC>3][B\"G>^@%:"IZ6]__S+W*SM2CRH_Z=6L)%9PI.@24\X?8KA=@DR>X6Z
MS@@>62"C6 #(&NR]/SOI=P])K[_?[_9>; SVGGO"7K?S_O*D?]+MD?VS0]+]
MV#G>/WO5)9WSMV]/>KV3\[-O <4'RL?@"X8^]#^L=JJD#N94^UO,K+?U^6<Z
M.K]\2U[P*?6$5$23JEUK"9NQ4CGTK0CM#;3,KZS8GDTLVR]?WOQYY+X-SOI@
MNN\]UO!HIPV/])REO>W*F[RA\6(#H=W[>VT#D/ME]ZQ/+KL7YY?]O]?:+MY?
M]M[OP^+ZYP08NP_<2\P&.;\D9FO-7B?G1Z1_W'TQ","Z2S%^S/3[G3ZV,=N-
MYM\(,6B"$7](+MG4#T*R9JO?C(+"93PD[ 9:DD"\9O;Z#K@L>WE&W<XQZH6P
MX;K2P"OF6*__9I_//KW^//_T((Z5X9&7)6<>[B"L$V@[MNEB 0 S+\O19JV(
MHS/ E?9Z; JC#,"PKI<)SO0C,7I(!RZ#%JX+,%@8$"S!FO#WE-JV_OU@:#)6
M"-I3H3*_7H1VSB#)V1S55F)U+"\B:XG4T!21I)*"L#*D$\<%;_4.&)='6J:[
MNJ([Z25>LI'#,886HH->3':]QO;DAAY:D=UXM*(PS64/-3MW:>^L^Q$$3;=S
M?'9^>O[J3W)\?GIX<O:*G)QUJK<2F/IK:./_@E6;DT/."H)Z>M2KP<1L-K/\
M0$0J=>1AK3L'% G<2)&B<4(H)WS*+/1!;>+ %H:<6. F )SK=RU_0S#!WG.Q
M7<9T_7'X;;#,;S<L"!V+NGH%LFDQ'ZH9&_7?"AFGEF&<$P]V<JHVLQ>"6.S(
MN&S'MU?P4?#VSP_ONNWF6<]]K/C&B#@&#D(V#?P;))HE^5U?9K1;82WM?5B@
M/SFZE<5">PGYCT M8E;33L&(WW0[6YGM/')<!@L'E5:\=]V#FS_[@^:[A6L]
M7@8VEK<FF1>#4&:E:39;2_&Y7VHG^G1^HF)OEB#8V[;E\SQH?WACC5^?/\PB
MRFQ+0?!T!1#@U#0KS79SN[[=OFN3;E-%*TR9-<&;Q ^('X[!N/H4!0ZW'0L!
MD#8VCDZ@)6@*)\W4ZRMIXS;Q?0]2"OWI2LMKK>-/)@['%"Q!.B9G?O7) %DU
MY\DEN!>3J>LO6*"Q(7&3W; L,$N*\6_@A11PTD&&D_9M.V"<JS].'8^9Q5ST
M^K _FYA_S;?>;3^>BUK+7%0 0&GOTO<GI&6VRZ36VC@"&]D'T=)O?$</XG9%
MO[R(>C$6!^SU?#IKFJ>'P\=C<?,^6*R7]MXYU!M3AUP$;(()CB/'P[H!(K(^
MC+S'4'G]!\)IXPZ<-HIQ^NEUO;W8V@\NKA]F,F5PNG4?G()K\RIR9M0S]@-&
MR^2,>GP,2SA$<QQ$\ I<EI<"<%M%*^W 7\^#OC_SBM=Y.?3_W#P\^'QN?P7M
M;*]<9S(]^.YCYGV!_^Z]H,W"!4D#LG@UC;^&YOC Z6P>.%]EZ*I*AT(SM[UZ
ML;)7::\S!J98L<RE56X7K?+"!UO;_<N9KC;J:\UCNW8<;)]^?GP4M5Y;N9@,
M!*6]EKD-[;\[7Z]R:2,/K$8LS2DM"8 CA5\D1>2PU1@=V]:7CZ/-P]%7(#03
M;4A/6=K[;[.Y G^553"?^F 178S!7[_-%NULM6NC:/1E?#AZ/. 9[RT_;VEO
MJUDWFUM;MYF?WX84UA1]EM$.=2-T\\D79PH+M5F94,^&7BZ;(NS$$\"7C:0E
MA=U03<&2G0;PQIE2E[ YLZ+0N<%0"!ARC*\_T2(>'=A9,N@D>K^ED:?<<Q4:
M8@&SR?X(7O]0[&YNUDVB2D[(/FQ@9\P6S/-@AS7\VUA&^<WH$T.*0(CWIE)#
M42E91:44<8XJBG 6W !Q/A5MWB/$]K13?(HX^$E"03*PO<'5)'0Z#7S@0W0_
M!_Z<#)CKSX@S%"^/0"V3[<H;,G1<Q(O# 4DA@\VWC= GW)E$;D@]YD?<71 .
MQ,&'"]%3=? ',+&@&8Z8Q#=!$N<45 2;L=#OAKX+LV-'#'(YZ%_RG2<3!-\I
M=GF+@UU:<GY5_UJUWG*\)PU*KW!U/@1."#N*#GWD*0^:KS!X.ON;Y^;!T?&L
M]>@DU,#W748]40674X"9&%DA6+B%[:UF<_<N%9B**CPA"A5,L-8T4&0:!3Q"
M<@:.P%H1TJRW%&DC3?= L4%'!Z;:MT*R9FZ1SM$EJ3=J56BXOB*'<2^B*8JB
MI)\]>+SG([=#16X]WW4LP(8W>@L2!\2.NR+AZ7:GP_;GZZ-7#PM,W)/6,H&_
M99B^,Z$E ($(DQ M4YG9I!6SGB*T[MP"MW7$LF36K%5ERU^%TG1,^2)@*#VP
MVE14IJ#6"LZ'PU5&_/[\RV'OX.9RW'F8(WY/BLL$R5;#]ITI#P"K6"G([I1U
M9M.NU-<&Z_>C0]GV%R'$=C$AGG >L>!.<NSY@]//_<_SF][X.<AQ\Q9R7(+P
MIR/*!JLTUZS[$26T-9O6>C%5/EDV_8G->BS$B<V*('$/TZB %B(=8@K^5!8V
M+/^G-ZB?J/@FDYM\RN*//IZ90H1WJ34F'9=RGB_7R*] H2A>@@#^D2G;[[[\
M@ HGNK>8#'QWC:__2HL_4]4\8NMCH0-<^&'LP),DDG-+_5*\-%C**/!!B('X
M<_U@AP2CP5J]UBS7&]OE>JNUONP_/G-E4T[%[6NK7@JCA5D?".)?$28];WP\
M_C2+CL_HX\.DF91.?M[2'NHQP'8O]*WK,O%\,J4!N:%NQ,@43P/A88N':+&'
MYJF?#=5=A6K%79*YBO&\%?SU*HPFU^\/'I_4K6=22IE)2WMXU/*G1.)6CEXU
M@ZZN@'P]N^;'S@4_N_ZJ?!:#B8J26?5V$3FGP0)L4V[3SWE\$X7I#ITZ(?B'
M;VEPS<*?RHA9$9L\\6PT[1@9+(@EXI30ZYK,QDR4QN1BB XGL,5@%^+ (P+R
M<A:.#; 0IQA7I)S8;.AXLHY21F=J+6T,Y4(S\-1L-QID#5>YM5NO-:IQ8T=4
M8$ZQ A.K=*2961]4Z@5CZ>TSDD&;R:#-:JI?,FSU>:RRKQ^NFT4MT:A=Y>[(
M)*;N]4ITZL@^Q2SVSJTOWGV>C;M_?758,0RBG*/3*$BP%L*F?)S-U3[.<]+\
M-^&K80&GZ.W$[$<AVSGYJ+TQ!J9B+C@7P%2>+UR-B#/1"J85R0$B[F9PA/LA
M3ZB*] G.Y2YP\ID#4R,5>; B>!.P&X=#OZ$H9L%X%[5$#0 VQHLQ;!K87&8%
M[)2?8Z3]G,8:C?V<M+]77:+5HRRMSOLQN/*XPPJ]NCG9XJ<'FZ[]L#3O_5SR
M1D&=_#)D=[OB/V=F*M;]W^\$:>J$:*%3D3IA^IU/D/Y NX.KVH41/D<8G8&)
MQ!*%D;>,[%N<M/1FFO6"W=P4]MQTM=V8'6,%0:2QI X^+\$:,'I=&3#@6EC/
M5*PO/?)FP<@(<1JZ%"HETM)SI2GCYR(*X>&>A&P">U<S21>+K3 A[!-*=.J$
M'**]Y8A2COU1P$3$KOIL67^EW=1#T&$,!ZU51?;T^;5J\;SGX(#FS\F589IY
M:/09. +@S(\6Y-AW19SDQ+.J9<"@KI9(%7>3-=1E__G7=KU>VU6&BOAE[JX3
ML</"L!4;P!,#%+0C:#_0R51O0&:@"_7:B/<G'E/H98L%(<5C1QZL,8P0$-A7
MQ[MA/ 1=C4K*1B4;,)BX:.! CU?.!"1G(@2"[3O:/$< 1"F!@S%G49?!F>NB
M-0)+2@4V;2=@PIH>PM8 DM+3GJN'>M8=LN:L$T!YPVR4ZZU-HFZ0 =/ DN$!
MCN&!/'+AA2'B!C$VE"W1T292<3@A,XZ\G")9/PUA'?%^3$%3B_#0OVM5LY4,
ML2M6ON8 V-. 58:1J+"8T0 -+HZXBX>(IOBST2QO;F^6P1!(+2X=^\CN"XQY
M),8D']28\1IO ;#91@B-Y=Y/Y:O\!*S<!RQJ^B*6ZZ.1ZJ?8VVA(]JZ2?HJN
M@589"$!;5M?,'<SBN@OR[S:9.*Z+C WT#08X%R:M!3S R3#P)X+<]'1E(I40
M>+!V9 E+> J*4_*SJDEB#-U?VP#.%)/8"8>P^91YG/$L9+)\AZ>-=H^%MT A
M#/>9'UP+!*A@ ]#+U,>Q?RU"*. C,@/Q9( 18R-*$7&Q$"R#P/.1IS1SZ4B!
M9%B@@ R>9WX$@XCC/S/PA<B8WJ#;Q2,WE-&+W."A/Y(!$2&SG9 ;=(A55T %
M@B9B,1XP5U &B"[4#DA6'NAH]+* )OV9)^H,D-!"+'MO5]OMWS2L?A0*[TNX
M84+8:1+(RL:D<LO I^ -\6@B+^;3+?5"JS(VOHQ+/#4/ZV5"XJ'+Z8S&84;V
M84FIA"(O[5"*>5A$&EB.%F.&%&,UL%1B02N9H6@?<5357R2RG EH.4?R+6)S
M0A> N'@*6TZY(,!W()3!6W/E!BT/;:2&ECLYC%R7K/%H\ EUFJ*;9%=P3UC
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M\@<]//K0P(&L7)2W#":H-G*H5EM8G+#G#\S8;\>YR&R6?GN[56NLR]3/HTH
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MS'7A5]9_AOLL'WO):?.?L&8FK-GXE<*:WX\N!WN]DU=G^_WWE]W>TP<'DPJ
MQO>L/+C(U=JJ;)/,>-VW3BQ='P1#816S';D+F5VR,]4RLLH&$[3R9D=,U0S8
MF+I#?8I7I/1D@[*T4B,O] TQ((W"L1^ ,GBRFICBXM@?.BHKN?/V;[3A8*@9
M7Y;J3_W%G5OJ3A\1G7SP8A[V\;G\\+J=VHG-VNV18-6L]:01W8/%SFVAZYPV
M&ZR,KS>>%JP-OD$^, <V%';SU(F>82.?$%JA$W/1HF?Z#"USQ@(E)^]_;)2(
M3S(5DM93^DACAPU!#>C/QY^+S\<'/]6'<$I[8'FSG50 11VC^S'3E_<QD5NI
MFPU.*0__L9,! <U[V\D_2TH^,UP&(Z%>_MR>[Y*30_&7J]KVP55\_HJ+58EN
M[/7\Z)-=>S/[M/]V_%=[M#4_V#P=G \^GXZVCOM!]TW_=?>F4XNN_WOZX=-I
M_[\7?[V^H7;MW;O%_G6K,6N]&\V[ETYHGVR?3=^SR]GL#0W=]V]]WGW]RJH-
M;GIG;'!P,>/;;]Z$?];_L,*-K7WW<''H32?=Z^%IXXOG?3SBO-MZ-?/GVV?-
MP^,W[^='YW\.:A]GYA]O%VYOZ_+\C?GY_1O:O?CCXO35M.'\L;$Q]E^WKC\?
MNV;OO7W]>?OZNGOR8>&VM]\M%LZK8[OQQVAC_/G$:O>[[Q:;G>O^*_M5U*8;
M;HV>-J]/7X5\^/I+N/EQ^_AX^^-QSSUY*3&R,?#M!?XY#B?NWO\#4$L#!!0
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MJMF! 7-17)9\'K?-%2PSB&NQZR\:6(@]/F->R>QTMO@!^(\;&/\B:^:@BOB
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M;*WJM. !:FV'&>,S0J9GI]_=NY>3XMBPBHM<N_ ;23"ZS4BR=S0R_GFY@+>
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M]_N@G"_.V[39R7[F]6<P2@6QT,,Z++RB&YS1;.]JM;BZ762GB>P<;Z;P"KI
MP$W/#(=;S"X4G;>.\&YQQM'A().&=L-E]\,BE$BT!^_+6?IC9D079/0J:&0Z
M^:>H5<F&/A.0H<UCU&%=H ,5<#Q#Z2C0976)%TF?ZKT!3]NP$/M/Y$R8XI!'
M<29[[^M(G>H_NHYVD+#\\P,<TMNYY 2W(I4JY\5@R%!-+&8GXZB5_-"9;\2
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MWF?^#4,)/H2' *\E^[FL+F@)^(<.K?>^X_X/M7QMT6SW2I$ 3V.DF"\L0LU
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M;$!)HOIL5\Y'+5ZO$97,2PI"X@Q7U*"IMUR,A'(?(;=*UM S@]6P%M00H*8
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M*5=?UCY]([DW_&#ZF*J!>GK?AW\)_>1[GDL_'$^Y%9-](00 PS8+RJD=<+Y
M_K3FF'0)K&:Q("R?(H)\.HZBSMN"XE&^2%RUB?_-=.+(UH2F!U3UN<B#J,#<
M9OSP9/OZ\U4I-/.!28;'J=I4ZZ+-T.*@[00G%RZ9W/22V.PD L6^"*>KE3U^
M66[J0:NH5%FXF[M!2VJ+" 'K^3;A5%"S<'T_1IW[KV<G9S-F*ZV;B)_T@# 8
M9Z' :)<;_ 9I0"G4B!4P9;8OB];>AA0]E*GAXE&@70N#Q:-HPHA7$!.RUVA9
MGX,^9'UNPFOV*O^EQ@YQO>OQ%*\KMBY"64X? LH%!A-/H;YI%8(+FLGNK*7/
MZ:Y&_]79:UPRBG(1X8%,M'U7^C&\=8D'%M?95RII&'+T=;PCVE)>IDV.CUNB
M5^/;39:).!UTT2$<\89AG=PPH-TTK).-1'6XONP#A'5H<=SG7<+3+]]TXM9&
M+*-D<76B$E!WE!3RTM75KZ0#F61^!?N]=SO:B/ZO)#E04%G<GL<!CS@Q:& M
MK28T<,$A:D5%2\+5N-5T"1$R>%CK36U[%-8I4Z=[TH&DR45W?KM8+"S-[@U_
M_BA9T![W/K;'U8/J;'Q/E$,(\X0\^EZY3?#AI.QZ\4K= _B- M-#Q<(!'"+B
M#PX7>>(/19JAV,1R&3!_<-R/9GJ7>O\P+(W"+'1:B:2Z<"./N7/]7VSPG^QJ
M%$ONR%P+[[7&/9@-"(2=@DM2"6,[=D?F3-BMC-6@7=6H^1JJ>WZ8 A[5B#$I
M>Z]]WU</XH\>UBTX"8SUU.UEN;Q-O",?.Z3TX5NE^09I A,+N,M?&*J_!]FS
M!F$&V^QGC$C1CS_3,=064VQE<63A,7&\&G;91,;%].KCE,HH-ZVV7S5F!P'T
M')76,J;W[RS?T0.T\&[691:9OPZVF47=T<M9CX=ED(GPXJB7DFVC-OPF]V3B
M:AQ?2>W<"9@<32;163:>E3"91 S<OW.H6$I^S5BSY%#A:^%R4Q5.673IP5_3
M>04! ][&''7KQV9+KF]0/T<HWJZS]D%%<%P"T#3(PK4#E:W^+_NV"OUC8JE@
M^;ICMMKR#?DR2M=XUET)OM8_]J$CVXT7Y5U-ZX'0S!&->G>@CVWB/N5NNO&4
MV2N3P\HQ%W;,S <1CU72:C9.N<@Z@(W;TA'E>B?M&VH+SSS] YG[PBN/%S^[
M2Y^  7:H*]-#[21!+4%4%H7OE9(T\G?NH2BBZNT&)EN1D$ ZF32D%1E1E&3W
M%HA>C-FZV43S7^*V=?RWI=(G#@[]4/M+PR9E5.J0H$<:O3K>0L??Q=RK!9KI
M>X=H&0NJN@9 #A6B%#7Q&*3_@EY G'TLMLH]&W78K.(N!:)/Y9"Q"U1R-]S@
MM>B_%5WGJSAUCPR1E.L_Y:WS/SP_[#>?DV1C2;)O_FI)LC^TT:QNP]*P%TKH
MY6R)M1EP*].MR<KVY8!9K'Q#G-%<QQZIN0$8SB'L8M\Q'Z2#).KM5)?II^UZ
MI#%20JN\0FB LR7(F#6X:U),4BPND7J=<2$SUB*C%N9S6:Z;+0_(TB=HPSHB
MRQ[YODS).9T:_731=HPY7\HEX-,RC2'VSV/+;^7(8= XZGKRS3OQR"4.QPI6
M7UI%M)_77&W6MQDB#6/AF$Y4.CSF\..8(NZ+_'_**\3M9'[FGGD"+.>KQU3M
MX\J^>XZA/RV?RF.FX4&94CG$,!.UFY<,VH(M<\XNIX);UO+55O6I7DOX"\VQ
M-KI+Y'3_\C+/_K5O-MI&Y.$%'AH8"1MS8D'$>?&<#L18B(JC5\LEPG3*,0;]
M@'8A%6@MLKH\)Y0RAKP0.(T7&%ALJ(VN>SH.(4\3"P>VW,C7/SX\Z$-:_RL^
MO1)[EKL = Z645*"S8#\WU("<3L7_GD#5_20. GS,G>1T:[=Y A:;.) O(2]
M5[,K%TBL\/B-MEZ0V:K,ERL%;8/0Z]^B06IKPA!J)RE6Z>C*R21922K=8K0P
MR^$1DN?<=HES8!#@3Q5%?6M"ME<7Q/D]B+UG-O0>7M.#EKF4%.K;72E9P!8S
M*[0!!H:INX=7+^M@QMT<YOO.?!Y1VH^S<.E3)0@"OQF8=H]I*T-<]GQ\G#H\
M+"O ,M,5A?@SL?W29\2[QHX<DY)S)F*2:4<GRPB/BK'@MB)+]X&%2<HPS2K&
M9LCMI1 3Y18D\.2_W#,]W8CI^9$%[(\AY$0;0>B;&\22#W2!'0_4XNX?C-!V
M7 41Q!C'HHLH\XG HDB:\QU<H#&W\=RQ[C,^NDM1C'<:WLV.B>[&2_2N Z#J
M!?Q2$Y,4;5R7V(A!K#>,DA^Q$4='>&\<MX85N>$$WY<!\T>ZJ_ <_^NBK-E#
M'#F>\W)1;,R)SK7*@JH4!,(C.#9NR=+3R"VKN$ 2=EO=:>OXLP/J;:K\X'#T
M>DCW"\Y=CNP*4\K,!N>*,.*IH"A0R^5D[HR**Z+>R!YU%ES$-KX9M9X11*EG
MC="\4+K57M0)7.JK;-LQUXNO];WXG/)X_)#?HYGN1!-I[6R6-"00=\)WHFR4
M[7+FF!%N,/;L70_]4%+R6-D8-O-&T.>283341R@LN2=T+UDYAH!UA1S.!GBT
MH)NL(3J&AC^8Q1^(9(,^Y"4#ONY;U8QT*>^5=\%V%W<;<WQ[\;"5>':BB*8\
M$[H[Z=5&V21TB);,RGC(JN6:+ ?*)(L6<9GG;;&]R%C=Q*11V@;(SY 7L6,(
M)AF,1"PE,$:EP)2L# HKT1-4%*URIQ", I>1"#O VIMS!"7FN\CBC;9C0""N
M^HR]<<^#XS6)A25:Z33]!C6VB/>U"RBZ1J5QN=?(&;O!&5(ATVB>ZT@_TFJ=
M!44YTNG6[AK_=4I4_@4NQ<L9[-D@;FT<Y6$(U:I_D'ENPW(P=IH?VHCDS>-E
M1W?G;QG3L24<M8>2N29+G>JT36&;<LKZ(LN(LT2U;, NC.V&*'E7(!?(NG3T
MVP$<NK2MGF0%P#:N:E1IBV;7LI&O(>T'HA7(S'5@+47@F[8*$E$X;N39-0.'
MX\N'+UVCZ G/=8Z@7PV2S'W]N/E=SL*L013M#\H$U(_GS[A*40PG8,Z" "F*
MI/9$9RM+_*4%!YX,3Q1TQSV S2=1].<@>B.4M>%:/)A.3F0JRPJOBIHL^=B%
MP;^_KBBULUB#F0_J<EM4W$M*G/_AM.,J%.02OA2Q ->;9L'DGC (Y73%VY(N
M:2P^7LY4%A#M!+;D_MH)&7W'N@[4 M]=N&95D-[V?Q,FH@N2IY$ R8?,:%R3
M6/[V<V)Y++'\[5\ML?SQFS!3?'HZ&02H/>#DPT7JF?C_8.;GG43JCXC&QW7?
M.&HL'_$Y7AAJ$58\46+-6 _S/6-@2(:E]=&X\9&.Y(_A@3Y5L-B%4EI@N4[K
MXG^?6,+(S6\85*-A[9ESS=?"P<(R71486P%&/HZ3G@DO*#7I+L69?1C.U9NX
MBODX<PU7GC6WLU,4>'W0C_MU<:4-26%Q76\6SYE!=<$FX<#0MSQT6S;-DM,:
MY"@2@F^U6U,.?\%?9,=-#&3GZ!)X;A>X5/&<4]T0J0N <2\=G1%10XZ\F_X9
M\JSJL-4JMCLPL'-C&@U:&'C9>=,L,V?B^: UKJP^YU?P++MEM; EM56P441!
M>U[4TLE3[5B7/G>E)G87T(ZD4 038;2HTAH\<EB\D:C/D[(AV_9.O%@I1 Y>
MB6;W9@X/<X+LTY.18&.%LNBWF_3>_53U'!-'/78P;8PG!#<#+K;TB-$0WD],
M^1KP(W@>5Y?Z8_PJN7PCW;6#PM5U1>A.5I-Q.^]AZB]"88DGE^YLZ^H0B4]F
M7;TN.;KDBC-]0L:5DZ+BZSE;:U;#2Y.?\,CD"/*U5N+N(+_#?II,</ \Y\5%
M2S"=U X%'^9X[#7#*6,?<^AVY^?,P>EU&<:")+,6=4VO;+$C?<>OAV:0;0"+
MEI.>_JD>D%\/-S._G?U,&I&M_L0-GPHB$CCN,*XZ:4((F:")9!9!9WN.B^\C
M +7C!(ZH74DW$I):Q' SQ% [VBA.HJ]3'*U%BG!+FD>3-2KQQI(B Q(=M?6(
MGN#IFB!RKE+K+%,365!+Q";VVZ#H7T+ISE;^$XGL,0)[BO+ZE!?#8S9=\R()
M\<()-S6;]ZEFLV+[R.,<*$$F0(PX+Z$?$M(_#TL9+?H>-(J9[Y4.(@[2,4,T
M9P_K@U@+19K8^G]WEWBH';4<[_=Q_0WW;<"::,TR2'$\_LJ'+U%AFM5"NE+7
M^L?_<C[\Y=>TKB?/B[V2&3Q^@S2I)0)>S.>^P<]-)R=/(Z8'0FPA@XB$S[CX
MSWSQ6W[!B\1YD6=I;XN7N_820]./)*VJ>98@(3LW^0K6*ORA3KY,FL<L]7O&
M#E(%M1Z@']]ST6E0KOWU[<QLVI-2$BJZ>U253=%O+:Z^CD9C-3NY.SMY- O)
M(;1[+^K;O=C$'>JHE;ZQE#>.1J135#LDXJ8L6NSW9*VSR93=@ R/F>52N-;I
MQ -;.?VPE84<0:_*X!X6W07Q@S)JI+ZE[:W1&)=5P!5JKFA*G+: !;,+A!>+
MO@>='6T8Y: $^&Q!M(5<*N8>\Z0(&;.V5]))&W>C/F\9OT/[-'/)"?3>!ENF
M!7YJ*_%:.UJAPO-5A*:?NE)HV+IDK[14]=]VI6C@R6VV8/F^*4<*T?S]+6<Z
M>8$_8&?JP$P&GNY"B[^,C8_7$!JX.#>AN#+MR+'%.2>O>.Q"&$4OEW6DE1V1
M_9'I@?(C<A]*#.F&Y=+N *OAJNU6MS#*1AP$DAA1\($VGX?.'5\GO&-Q42XQ
M\4H D,XA#DU<APVM-YAZZ$0/^.P=[TSX.]#9VFLV B:$@0^&?.M'#7DH/]+>
MSK3.*K#<#6)%_8Y\,0R,I.^;MB[W"H^^D38:;!"?M[VX/RHIA"C $ +UA<.?
M2FKVY-#ZO#'186VSR WCF=A*\^&!IHXB*STS)/S>5V,01MAU9KY&&,?K/05$
MR+FA3_K/:*#$&PPDX.V>EU>(W,WZQLH)IG%9P55%FTD=2)#79B^W1IK=P\<>
MJ;?YHMI*-KG62(=$E(9"/CSIU1L9XV!GP>YO%ERL[L%.9GEJZR]B;1<ZC/#$
M-X=.;S!WV+U+B>6@9@"]E^0Q<UK&D,[PR[6!2E,LNXOF2DF#"#Z,#&+OVTZX
M47KMN\_IM;'TVG=_\O3:O%DOWY-0O==7.:_C=G:=P_']DY^?O0KD*MYY.&WX
MF?=EG'_LN$\Q"ZE?U6!'-YJ7CJU*I,C*+HIV0WUEDSD7M'(-%[56_6N?(\ME
MF?R^&@B>0XMH\(3\.L6A-7*3D.T15O84B7%IU:=GV)2&3,$CI:HVC[Y7<D\@
M1R]''9=\U:>3.[AF>/ZVWI-CGW1!"(V8PCS(OEH7U0;AF-S+%59!RW=Q&? S
MG?S@+R,A;9 X )GYTA(69K_>!Q2T,+R?_ <3O2\NN'*EVLP)S,/4#<,9,0](
MTIX^"?G@325RTO9NZM*E0/2AP_?A2I3#0DN#572<=(I5/+@(UMEU.Z.Q1<Y;
M>2,0FT,GEH!:_E+SIW,)IK.MSO_$%DQB%R[+5>DZ4MB2@3R+T#SX]]2;J&&\
MQ'+4 $;W<X'$@CA&9I%ON8D5AH6:E<0F(Y,U'X'STL*7YY3(&$!]\>TADC="
MNHZGVGE&"9R?X[T/.DAJ<8-"8,W 0"'H+QW N-=6A!'0^$8XXK5R/O;70HBG
MDP,88M-F*%[#[M "HQ69A[A?\VG_2U0<>=AOP*9>X;6I<YK" <])>6$*O83S
MOG)5"(GO#\' U<%ZB9OM.&'R*-SAC_0Q4@Q^W/)2NF(.NZ8VBOUUOQ&I2LPO
M;'@ZI+49#1/1(E#7#9G5\.'.RG=LN3@7_6&$L9I[M=/L<L.*&O+N/CBZ4[O#
M63)2$NX7W$->\EKUXC#A.&?(+[RJTIZL^ %S=^"0'AL]'BW!="(+S#T1J<BD
M)@Y@N- J##9@>XV2XZT<>9=$$"(],1$D!*)X6XX(IUM?=-#.6T1*UN4Y'&<R
MM1$]BSC&U6Z-QQ33!;M%W +2+;L<?UUX6>?<[%<H:IYOIY@W7$ISLI_9*CYU
M6KWJ% 'PQQ<& @9.;5*D8X$&YP5SL68R2?7_MW=M/7$C6?@]4OZ#A915D#S0
M$"6;R630D, FK$@F"T0SV=4^F&[3;<5MM]HV+//KM\ZMZI1=;IH$FMP>$H70
M7?<Z=2[?^4ZKD""++1!8$%:M)<?MKU25'X;Q!HK"T%?AE^#PH<RU*K3$47>%
M6_4$\JIDS1+Q5;YJ$918K 3L.ZL]\"P'UBB%E1W:*&[@,#IZ%":595?)*BH8
M?9F4 :?KT?L91%DQ #NK25*&M@5.-1:2D[@6'G/-%2CZ;-]3TL;Y2?( A7(P
MI LE&*2H0FASXM[&;1G2Z0RHZP.\[^[]^Z55L56Q)O=),7.(ZS+4JA.9"$UC
ML(7FGR']WD;INN5*(:A(-#N%N),M(9!=':I[;A])X;ONKH2+[ GC4,TYB+U\
MB.:%1Z%,#R6VRTL2J&(5HRO*497UH?" ZF/*Y;)!_W6"$3M0Y\:W%\C $\53
M+(-K4KA)Y%2^/DU8$ITZ8\./RQ(U?^_!ZG*<TS@M]3X$JJA=S=O/X7LD<[*.
M39O\(.M2"Z$PE%L,>RYMGJ@'G3"S8;B+!)' Z=]W19H"[/=GKABG2J"&_4Y'
M[O[ N];=0&> VX&(_@8?*Q+(G,2)LK0/;;>.0<&UG,[2D?O:NDT[[)M&"R6E
MV/GZ=D\G8F-0QIDMRCIE/AU]Z@1-A"6N0=JQ!(3,NSPC-)74T*8/,Q<K)V_*
M9J5@ARK^5D\\6#P(:N:E3\B%<02I=S$T H;+!JBS0''SL ;:EG2J97-.5'%E
M=FR<4\:SI_NY:*J :X+'TQ4^ (L>8V$P4*E,L<#$%R';JQ*KPX-1$@K3>G9T
MJZ@TN52&CO@H5(Z/]5P0S:3B"F] 7>?.\O7[)P0!QP_ 0@''ES R<7 L>J@)
M0KB7IE B#+X\2?/1.E:ID(''/=OC:)4H'@AHD7:7K T&;L#R@XEYZC$&_.=@
M>*;X[$@G\J)@36I>&\LN1Z!\]T)5:?K1 R92&,NR'D2*6\)[#*R*H/(+/4>N
MC,E%@1B6PXJ#.[#M9*D^*0&7._+<*^LL+:4XA1P)O38Q@A,JX?!0(!T682@R
MFL("E3#3G H^0K2T3_]%G<%LEC:V6D9Q2Z82!TAPL:(EUXHN2/O+%AC%IJY]
M=C"9[?22JX!E0P%"N"3Y9(J*#+]MNB*PRQ/$\+USH=%H^;&)+0T32YD8G:3B
M&B64JRA5F8K:$NC]_KT1@^3-R&ZS6.Z-L:!N#WY$TWJB:=N#KSR:]FW9C@/'
M-GW SD#2'*R. 2L^+B7)ELR[#.SMY-PHFI*#T&-H.C=JH%I R$?7>C*MN+/8
M2T^2*JB;S<UE&6'-G["WGXO*EE+J#*B<O0H#5/OH#+0]*&6_SBHF^&C/;0V<
M+@<CA_Y!;YH@PT)2+.)#5-",D/DGK>$'L#TKDX4N>G&Q'ZO39RS)<U"E<,:Z
M\ \*[ZG1^&'F&( 1F@QV,C+D=@8/8RWJK^)#R9,+<J*#(U*0]^VU I,(+3=O
M*<\2*#+;SGL)KV,(G?LIJ]CGEI-%I50=12K;YRPE!99(X2Y2@#M5:C"@(9R#
M0QJ>7D((@I9A5IU<[55;IZ?*970!NYD3ZC)P])8+8?'[;",E:*^EF$W./MN>
M0)R83LG8')@QS81+.#E5NN,M]JY=AJ4X5=H]#\;\=(:.0K*S$-?/>0$]7"7]
M[GLJ@:GS 'Q"EGBYRVGNSC5N9^#47._J605K!/_A2)1(RE9 W^0+( CB8YRB
M!#Z!<] ?K%3S^F+2/_A579(=)5F;P4^V5]X*62G2K2@U6M$)Y_-71;VK83E+
MNT37P1 H0;%5!Y2S4S53<*6;13V%JGIX8L&#:6U2F5UH:X*^WNAM6<,8;<(@
M'D9PZ(-D$E# N,ER8E0XFR<-("$+C/SYF1R4R"PE9=.DX'*C%D2_!02M00HI
MJE1#6:"Q.P.(,\A3J8CF='@R$=ABN9@8J</IGS12E/>+AOH5985<RYL]8O;1
M0/"!SJ39T\4N/M]7:^U'2\AB"Z+*<V!.*?VB+N>U9P&O6^>DK@@8#&=&*XAF
MD@3I1[VO,)I)L%./-X=<UK! ^M%X2$1/-$";7=).!_Z\"*.QG9<),2X7^UIJ
M&8*Q1:.\\NI\7P&HU!(&<UQ0&!K$;* ,:R7\ K4"NV7[&!?":4"::HVRS'6&
MA%]04Z.@I@EB?'HRV$'[F8]R5F/P)"H?$/CSV5_*">(JD6_!07.7A%ZL'A3/
M:H*6=U10\NE&=$76%\K6=MJ7JR>IT'^9^U+LI4JV\C!CS1'M):!8"$^(4>G^
MO5D8XNBL$DY0<FA&:#Q<Y-(K/2&<4?U"G7B:Z)RB8A8\J''@I/I>-_'FM4%!
MP<B:/[FYH"<R CG5@+XDK%J1ZE*HQ)8EG!'\O2X"LY_Y$N<JR7J:0)6=?#A&
M"5$X_<H(5H2O>CEAW<O:T0QW06B#C>)R,SM+H=(V+?>"+@0;478&SI]*]=H"
MMOWG):C^P2>LB6(]IRPC8U] TJ.IQ*EF"K? /9<KNRKHP]UE//Z,BCY(51(1
M5 1M.FT*?@@J7;[8;H!"S'DT#L8\F!?@U31&@NG9JP=O3V:,]I_\2'I<^M.4
MXJS\J$&4S.VO#9PR77 BM>5OL/QJ'RGD73!08B9WC[4F/"M4'@24(Q&,;)V!
M.5U0'N:'+'JX/YIGP_7H55/&?24B8E[^9]'EN"E_:[CL=U-]36_GXOUSZ\G2
MY)NH.$&=O86;=I(.)T69E^/+Z+61ZG S#XKAS<FMQ4,X*HVA\'CK9V-+#1YO
M_B-ZD0.7R<FC%77_KRPI)DD6O3,/?F;D%%&KF;V&@"S1MT.!ZI6,Y563721%
MM#M/DSAZ:RPY<"ON868>*!S'D[3XR_R)H>*5&:99M:>#P6!%@]NM:_/O/])L
M J1>AUFSHG[W2;Q CI$Q['XK_E<;(36<;)BGYE;OX?,#>Q4/=I8,-F[]"#;V
M!1NWOK=@XTJ5 OFCNK-QQ?:AL,?[#W2D&)5I=MD%M#B(,D-3@0SWF;X+=S#H
M.U^U-\/#I!E/C'T1_2V9SLSE-_?+=')X^.X.1[7]9!"]2499!?[RW?-T(XZV
MG@*E2%Z6\SL<%[3[H9Q_-(_9!]/?8.O)'0Z&WB^S7\"C?CR<-$ J<//C^?LU
M#[/^^]^3I!S"Z\HI=4?F2B;S$:?217_>W),;6#XUMN[X[3-\?/SR]?OCD_VC
MWZ80D,:K  M9W.A['%K-*\;77<VC/YM;'>25XUJ!%[BWUUUFM[B,V.X%IX]P
M-2HC$'T[DJ: (%UMP(/[:IPA?8U@(WW^+>)V_<8<I5L#*#+,;JI*_)^^0QO]
M9EF!<7W/D22^LU/S/QGSI0HI'OLB(H]MI?-MA]='GA7KZB.:#G&"60\^>;O$
M8]JI6FY3]R/!P[M>_8QNZYEC;RHUB/!*Y],]9[\AE"=#5^Y,TE XV$=P7P+T
M(UN+Q!44*O(;.RY;0/UE=M8LU?N"\J52#G9:YSE6;C:-C#C'O6E]T*9Q4*.Q
MJG&#9';E>58%?:JZ^(T4Q4PCW97?$7'IZ@IP"_NC0[,1,3W@\;6'EU46N4+P
M:!4]E**)O#2M=<E3OW!V&[^!_G6, 9K& &[!]2TPONG03]XO,1T=@34JEQER
M"3^:4=2T;.3D=Z/XUH[K]D;TBIRM8,<G%P!YINVK?@$FVKRID,SOGXK0.20$
M+1#L*M(WMW]C[)>HR<TFRBF-*=]C!I3B=+S0^I@W=-CNWU/LUEQE3&!=7&),
MD'/0#(@L34R-6=3P@U-'!?I/(1R1P3H!!1L 8K!A-LO32A#7&_?O[2ON[!".
M4#L*J9B.@DH@$@)K1U=-5DO4&@Z^3OGKY&K[9."=T.HFQV>6WPA5.3&5'<\O
M!80F"P5T8E"F#;AEYV:T0#%+HLHM)452:Y!P?BU'\5O1EUT,R<S*C,;YM?SF
M$"*)=;X9OH=\B1BA)2!^K3+[YCBOY*Q.;<C(*/=-:F4<Y1GTKC0]943(EYDW
M\[P<8O*&Y6/C1MO4YDNOT?U[-"LY%Y^_0EXB7/_,-J+@,67JE?8Y!3X#O$^.
M79)XS9ERRY70Y#BZO%9"+3>#CJO*KRH GZ6<L." ,73GYZA\\MG[O(6E76+V
M&'=7U5QE?E:3<UFF&'DR5XMI^\P/\']]56!%ZVZ_:(#=A/@6%F7"/!U7!6Z)
M<<1+'@M.ZUO08.>H7#7#/CKJJV8:]4]4#XJ,E2XSTI*WP*@M:59;@MY(L.S3
M:4KDU&$)C*!=B?A?.OV&,=\=L#RK]T:")$3A1[T)NCW8AZ*[YZBR184J2F$\
MO!">5CF5PK;H^/UL[J!P"_838CJ&3PU6B#4C)FG_\[+"6!^)O-YYW*5V="L<
M9UN/C'YDK+&Y>:2=9G3GM&9?)M ,R<X@+\QIA9K;HJ;$1N"03UPBQ)EG#'?Q
M-\Q."L7/,-V/.'55?B8B/I/</C^LZIC_*]*R05 (_%;!DM#N%#PRUYE.QZ6Q
MV4A9:K,H(+::N9H)9&XMH9,@>7F*@7%.@;Y *#CD[E(".^BV9K9 _XJO<I&Z
M-$R7<P[SRL: MHS=+:U<;6',C*&U@PH52=W,4TO=BE/B?R*;DI7HT )8GZ!/
M$P@G, -.866T-(V>R]UPRJ9/=(0JN+^/VJE1E(I(GE&##YGT"-_]#+BOH< >
M+Q]J?+8O_LGO$I?.@K.GHK%S)U# ,64X%_M2-JSO8T)D4I4,)9ES9C*W893&
M+&7::STE-"(=2*5E8VL;A501;<.$T$]L1#MS>1%NB&L,6:.$$(HEE>@J*N#$
M+6K%/N9:S9@?2$I^*5C\NV9N+.$J5=WH6E''1N=+IZ=0=7X[CK8'VX^)N\]1
MO"ULRV>^.[UD1UBW2(_HGS-N8E[Y55S< 0?0VSB54\[L4>E\ZJR[A9.CC2.S
M4[O,OH"\U94F%9YZI)20"F1U^LHF/(7RL"SO46>Y'>5%VPK&.I:8SX\0\JG5
M"?.T&,-QI1PV,%TMI3D#."]2^%5TEHV:(=;3'#7ND>C4W=0>R-@Q9G3RAR[X
M*;)?AWM=3TK(Q.<.L'>%@?8PHX'WZ6'6UYLU3X7#@A?8B%-@FN(B/:7-U;:)
M%3Z; MO /'&$H#+IC$W]BSJ9?P3_1+9+SU(6$J' >,TNL+N!:74L1Q[$WLF&
M]+9C,9-6\*A\51XTCCQMA[$4:SO_>7ZP0VAH  B/I/8B9L&-4UOZ%20Z@^DP
M9P+&&IWF2?%Q X+H_UW9>*^5+;_] \#2!V#9_MX +%?'7>_Z63L@0:/RXBL_
MNYW+H%Z6S=PW ="OVJ@J3\8 )@X1T#S,!<[+"\BAG*>L1V/+HD*;QRJ',#UE
M(N7$AR-*OHVSB68_+$$!3VPXT%E"@4Q\3)8%_>;F9&9GATYV7QSN1R_W#P^/
MW^V^/'C[ZM>UP1K^_&YW;T]^OG:G%]FHGL!'!P^L! "VX&16F:,O_UK#<_O\
MY$@Z. >WTC#)9<?-M5B3LWVR%[W\'4;Y]M>U1QC%6 18C0@ ?[('?QU=KQ^[
M1N:?@<ZWU_0'KM^\?(K7Z/&#M9T7@"/V>A.1<87PM"O]")K9K#8!E&D60E"9
MH3;Y&T\&#SYS(CLH%T.+M=,_BL_L\@02-EJ+M=.#1[_1CF_Y3.BCO8O^=DYB
M0 E!-*C6S@$S#0C C!8G;A $[3_["B9G[NU[2@Q02B& YEY^N3?VT^\GW4D_
M?^)&CR5>P5:+M]C=35^_37Q_=K[$XO/]#8:4TNMVLE!]O86YV*:4B@CUY7X2
M-;%/L>_5L-43O^9]6ROQR@# U@(71*8*:BS_K=58;Y"WL[&;+W[?^P!G<//U
MR9O#G?\#4$L#!!0    ( "R1)5LT4W11M)D  ',T P >    96$P,C4V,3<Y
M,#%E>#$P+3%?;F5X='1E8V@N:'1M[+UM<]M(LB[XG1'\#[ASSSTK1<!J2[;[
MS;T=H;;E:<>Z;5_;/;-G-_8#2((2VB#  4#)G%^_^5J5!10HV99?=*QS8J(M
M$@0*55E9^?+DD[_\_N:/9[].)[_\?G+\&/_[YNF;9R>__O(=_Q<^^$Z_^>W%
MX_^"_^+___(R>?WFOYZ=_)]_6]95]W,RJ\M%<GAWW25OBE7>)L_SB^15O<JJ
ME#](D]=Y4RP?)JNL.2VJGQ.X]&'2Y>^Z.UE9G,('37%ZUOWMUY-W9\6LZ.!>
M!X>_?/?RUT_SL'E>=7GSMU__LYJUZX>?_CFO3Q[]^>KIFZ<GKY.7?[YZ]/OQ
MZY/D^.^O3D[^.'G^YDN_YD<]XJ]-VQ7+K7Q85(L<;WGWX$%1_>W7-V=%"W>8
M;YJB*_)V.GFY:>9G69LGQZ=-GJ_@VF2OPXO^\W_^>'1T]^$O?_[JOOGENS]_
MI8\/'^XG<,DBZ_)%DK5)O81[KKM\-<N;Y"A-CNX>/4B36=Y=Y'D%K_ .WB:?
MGU5U69]ND]]A%HOJ-'E:S0_29/G=V^^RZ>2?^9LF6^3)WYMZLY:OLN2?VWJ%
ME\[K9ETW65?4%0XO-Z-[5*_66;6U8X-?5HLDS^9GR5I>KTD*G(=B6<"(X29X
MCQ:F*^LV39ZLLU.8ZK.\R;MZ.MG#7Z9)4<W+#0VTZ-JDW<SG>=O634LWSUK\
M=8MC]$/1N6S,8.CJ>5V6^;PKSO-RFX3#=[]I[1L<?'[)^%(2^<_?3UZ='+].
M889G?\$D32==37,$^V35RO15BP+7'I8A[Y)EW71GL#P)R:F76[P4UKO=9/ '
MW"2KDGRYY'E/FORT:#L1H;8#R:7?;& P#3W.;XKD> Z;((/-L<B7104",\O+
M^F(?)5W&]OHL:_#-\=\OF_S.$[S/(OEGUC3P<!YU_+O@IR*[R2)O"_@0[UZT
M[2:GW[=Y6>(G*(U^GS9&N,UG;7Z>-UD)XH7?5G67_%4755=N4WMSW0W)LJE7
M=@1X _?ZL)OMX."M5S5LDN4&;H]STLZ;8@9O-%B!;TAJG[_X)]P(1??)BU<G
MZ73R]'GRZ,7SUT\?G[PZ?O/TQ7.=Q=6FVV0EB/!Y7I%H@#!W&4G58/YX:4&\
MDQI^VB2G=;V@C\ZS<I/-RAQ_W((B$S'&^S?Y/"_6+/R@/_^UR>:P2/#PB[,"
M1 1DC?3:#-9Q_K:J+\I\<9HO0O$;"E22X9APZ9>@NNJ+]N>O;6FO[R@^?O7F
MZ:-G)\G33R.^_)C^*^(+/CYY\O3Y4Q26UY_YR5]JUQP>'/*CX:%__OH8M2OK
M=3S[#N#4!Q%F39\$AX#JX;QL\PL4Y]C>P7T#&A"5W+IN58^%U^ M6:+Q7*>;
M3R=G&9P/M%?SK(+/8Z?,:SQ&8%CP!I]F*Y3YLOL,*L[_[^ ([OX^V]';@_-_
M;8H&)_ EF"UU90R7Z:0]PS7H3REH$CDT8%W!E#JCN<?9U8F]?_#]I]E_L8G]
ME--ZY5D]&DPK3L2U3.:]@\.]OZ[-B/R(E_OJYGBY+,H"C#]KH>.THLFV%7F&
MN<Y 5RS :IJ#!974S70"M]0_NS-P44[/P(O(X2NVC0K4M*M\461-@:/'0[ZI
MRQ8O*%K]LT13<BN?L>4YKU<K>*)<D%P4H',R'4?6^N4%/85G^:9EPT',8K!H
M-_ !W^O5!BR$^W<?C!JU-WB#76VY?^@M]V]UUBSP''A,BU<'3M9TP@N/\S33
M"Q=Z8<\*OL%3=QW[YK=-"P=P"T+X.-O&]\XBVXK9"ML'5!%ZUO 9C C$,2.I
MYZ_ICTKL4Y3_O)D78"+/LNIMB[+]!J>]Z+:X!/B"_U4W;\F0S3;=6=T4_\X7
M8.$V8/KB.<1[JLPN4!LV^0ILZV1>@@&P>)C R-=-?0X6\P('G>('9_4%^DK\
M-]H,\Q(V[;*8DTV=#D?$2AA=JED.E@A8$J1X9^\]GF0!GAU\*-,*3BB8WEUR
M5J]RF<[4?7>6E[#K847NK,ML/OB^JJL[L!P8T8!QYJMU66_SW DV6D*5+D=;
MK IX15@ T JDD< ;[)IBSAYUS9H"AXBA$)AS_.GZ;-O"E, <@-,*ZU36/#\M
MCABOYXV"AXW\XA0\G*9",PM^)3/3@2O2UO!C.K3H=SD&0IJZ*N;@4%8+^! >
MT"YQG-L6G/(VV?.!%UR>"WB0NZC=Q\>]E]"<YA5[QC MZ[RB>X(6Q46:@_3#
MY..D5*QI039ONA-['=O]$0@#S/^(LISSMZHA75"!@A99F>L7YO"Q81DU4HX.
M#F_GVLTU:M:868(3B9%1G/#'5G.B4I*)?H.[(^-9?5S/-[@)6S8;9QB S=_!
M2E"H%E9HD9<%[%164_CK;+TN8:O/RGPZ66<-K5?'L5 .2."33 ANC2$'?!OU
MT>0-4MBY^QSU<C%-?)?#'QXF]0PF110(QJ$R?O3KS0Q-V36-_'A5;ZH.S!QX
MY%XAMY+C5^[3]F\D+],3-XS=<D!C#J-(S4RT\-.68\"@63+X[2)-9IL.?U#5
M"1P,.((25D*.,7(8BZ;MDKW#MML/EL(XDJ@0X4<4:H%%V1.EVN8X;\G>T2^O
M_WSY:P6'$/[WLKN 1\JW*?H.+-J-&'?F&'9&1RD:J_@Y'E!9*"IP"BSQ3>[_
M?/=NLCY8'21[3C62KNQ L/=IC6?Y$NW85;&H,.LSG42OI(>:1WS>./77O7U?
M:TPYOH?ENL1=QJ$%#$> [P83B]Y)5>7ODF.\ 1RS'0@P+#3OQ,]F?][[:=U]
MC=,,1W[1MGT'V<_OGU6!&HZFUV:X2+I/WH$^JDY)G<AM;IWCZ!R#(+[NZOG;
MN!"+M]KB%3T'*9U.*E3L#06KP2I BPY3'7*&.',4S.V6O"N3<0#WN99CC<PP
M\]4*%!EN =9D,PIXXQT*U>*\LHMOW$'CM4,MA$MS HX(+ .: 7%G;3S;(R<7
MGLR%A#-D92[J3;E(T.7H2HY'G=6E!!KHN,*4&X4&X03+.GH.'AN)E2N35DTI
MVE'#X5N"A]*)^\7IL%F7HIT!%C\:*BW_DO (:5*O^<H+2:@YQ[*@< CI5CD4
MPW' 60RV0E=@(H4D#GX)IA$X$BTE5^A/%B?Z&S1SZNY^48"%*R_?CKP]Y6+.
M0>+M&]_:N"Y'/YT\ A.OS<NA4/XQ?Y9M3L]*.!3_,UNM'\+<@3>9)L^>O60Y
M 3D%'QW&3)XHVK)=<O3]W>0/,$8P5G9\GA^DR>&/<.63LL:54P,&_O5?\-)W
M#S]1@/F&+L7+5X^2T>7X+2_^0FOE_SE#U_V?8#D_RRZ2)T6S&E^-NT??W?ON
MP7=']YZDR>_YNRQYBD'1BO8U>.HOR^S?&:Q%??!3\N@LJ[>PSV"O3B?/*=$"
MZU=M8.L\A@>"W8/V9<%1BE1'D\(BWCV\FR8P])N^E'_[U=WH?]RY S.;EXN?
MDY?9:0ZBG_]KDU?S'&[Z,'E!VJ[]&>^JGO.=._#+!/[OE\=/_Z'#X)O?Z>HU
M_.X(WTP^F=5=5Z]^3K['SV84!7*?_59F<%P<'CR P;=U62Q@7.[%8KE$^Y2[
MD8?<#:W'7[Z#$48&.X,#_>T==CI^)OA->.OO([?&E[+#&\QF\# SJ]_AM/*D
M7<.Z?74[&O:)!.^F$WS08#>S8WY=SN1/Z$QFNYS)Z:3G3<:OQ(?"T6P>DN+-
M#W?<7# /=ES%BM(N'2*KQEWI--E4<&ZWYBQG:V$N"#:!"V5-6>"9CN:"A$=>
M8OR5YNOXU&$T*#ZQ:T85^W:)0XWWNF1"8],$EK:)45QMTDQ\ FSUZYJ.FZZ'
MKV,#GA \!S7S,(CW,1G<]C:#&YEL=>6/YR.1%HMNM5>CIW/XT[W[*0IX!B*\
MP."?(O6:32G!@B8_W929QCKKU:8\)1.'#'U*K=Y&O4[>Y:LU*+6G+8;UYR-Q
MZT*^Q9G?R_8Y'D >IW60R,5:NY"N)K-@[&QD<LYJ+#$[G820SZU&)_2FR;H$
M5;;8(#1R 1_EC+"C72=0H1256P9S]!?EK/0)E&23T<!;(;C9/5TSR[#C_<":
MR$W,[S**GQ1=E].,!+?WKY>W'7B?17L6&2A_D#?G9'LW*,(-)A\U$*]@SKW9
MOG7Q-VLY \3;#5Q=' J&4<@Y;DU"S\30")3*H4C: +1MOE/7>#HQS[K$H?:/
M,G[XB%S(4W%/UIL.IJ6B$]">9P+QFDX,QDLSOFS,].-)I(HYF0O'LZ@!.+51
M3/NW-2<[(G.K.5BM+5]6;0CKCF&L#<)S;4"EX<R$N=K-^QH<&A W-_?T=V_Z
MY;/E8.A[)KU>$&:DDM,"73(8 \U:NRX1KT[W7,T*]K\P;TK#@FV=B\:C(V?X
M&#%PYH$$R5($6PU#/6VA261\? -S=UK,.5N;27XY6^."<+IIN#W >2?L#$@]
M)LA'-OEEBYJA[:OBXDH7-,V-Z^NN52VUEWE8(4PF86<.[]]GDVR>-<T6K:P
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M9S610L.KE46^P:?*X\:S\REOP;Y=&GD.9PF,HL#GT'7@HE6L1N$!F])WB-O
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M!I]NO3:]--P6F;UAQ.S#IB^Y=/;XO1A'"S_:OXT]?8:SF3"B7M>EO?(E0T^
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M,5KSZC0[I9/#99JP979'>D;[,A+78KU:(5T=R;'9=PM'@$5&"B.46IX70<:
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MG$V5 [_%MEX%OPS1;1I5%_9N(49A8_5QUX;$%<VZJ"Y..>GP%/791<4N)*.
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MDU@!S4<:W;79,D?0+^/6?-\#+N^@+I-$->Z0<+;-9*":=5A<TD:"([1/&.W
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MW&R07L@2BC#J^<74 8&C1!_!IN(7YSM?G-6N">2 =6EOV"Z5J(YEI@\?Q.%
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M/!ODATGB4F*'U:*" P(LIH".Q VE4OZ/RCP2C_>LDS44RI;?B?#@!9L/PB@
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MF=8U=*^TL7DD6"@Z6# I&&Q*:1#VF1LE.2K?5\9^;R@RU2'!ZD46Q(<'?&'
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M.?/ZG1,&6=1K86V)>TS6+5X/QM?]7(43%.F1^7KX3I/%:[5$\0@7 ,$8-@2
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M^^G7Z! ='&>^[4,AZ9\4'O5-@/U7]S6LIYW#O8^XL-X.W^V[%_\/4$L#!!0
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MA3A_T6B#["4-R'5'YRWU$H:%CY)BFN#<J'6(=DXZX*N/7O3M4SIG7"(^02V
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MH']'F3-)25^"TELLOR9WLW*[AX3L=: CWSCG:JIIRC7 7;[/7@?7J17-KMG
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MOVON465H>Y0XL$A3FT=7LW+^KB/*HP.00#> 347@JN72@8(;,;M-H,IP)0+
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M,XA!GG8TQ4^QA"'_D]-G*"K_7Z_D!*_-OC&\!D7D)GO"!I%$P45M]<!TYFU
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M>?%GIU8+/96([AYKG_7:Y\[U:Y_?+D?>E-,;]/.;W#;GG^W\+U!+ P04
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M^Q*J42#\OG >$CQT#,B->B%4"!KLZMA.<[/'4SL!FJQT*,:D&JFW=V/64N.
MY?5J18;8&3#&BJX,L1%7]FGO_A;\!DYHX;@-7"@U%R!+4DQSD!A)2G.8ERNI
MVZ%89+10>232$GFQK8&*F' 1G5VV.5$$RL6[,D %2O$VS,86WVW4:J_CKKBM
M2R-<ZGXAE_ YT=+XTK,:A;TH$\T1]/P@"4&'(Y &H,#<&$5B@0+8 )& "#U0
M,]N!ALR 6U2Y??X-_\94Y ND-%NS4YI?2U:61Y^7]/R1TOR1TGQ02K/]/"G-
ME[7!!YPZO4+;QYD!86M, =U\+EC,/\"967B"]K=F 6ADC3$^'DC 0LXXNVX3
M:]*I5PE,?6I$4[.,9P1V\G4_;Y/_]Q0D+HX'RW=7Y=I2H5\Q0 %<@Y%@WOM#
M'7< 7,2]-'$:"('[*6<G\J;#8J)W,@51<^W3*7W!(C7"V"G/9,4$D=0(6!D(
M;/RDB E0*SZ-;=>1QE]9NS0\C)GF!/L;$8ZF>* 4M<)T!8> :4;#8;62=QRF
M@<)%N=>4^C.IF3,D[^TCB,8H@$94 ,3[3K1S+E#YD]M.RT(.;Q;:2/-]N\\2
M52^C\G^K+,K#%.0!&I(&2(@G7=J-9#.)\QP=C\#,05Q+W=@3H;\+'4W6&F_E
MTUE)BR9[S(@8;2V(">'Z3%,H^J9  @$/2O2"UMEI07ZAE,T_0F26E9F)B+"&
M80=)QAT &K 3$_*!\4$6.M@PG=UA$ ,7([0@$5;*JA4ZJ5NS!W:11D]J0S%F
M8K"(H!T% RXWX-H]!Y,!EVWM(:6%;&;('B\P>9_X9/$#PQ&%T2J%4S!6R$-,
M.%0KW!]*HW3-&KT1O"\L5<#83@K[U, )URA;Y<:/;*4B'WX-_+\TJ#Z8D (I
MM]:^T'>ZL%N56N 7MZLN6Y"T^MQ[3("YVLV.!MC3#S:0S"U_GBB4(6BLRYZX
MLY(<>^OIH'46X,[KR@>3$"2N[U49,=]$@*\MGK@HGAO87+/9GV9CC4V?'RA6
M!#HN$@X*9S)-?MI'W'N H_,M)EDCWTMIR*X0(?.38 QNGX/L^A0$4TIO2C>(
M-R-IQ/.XP7^DI1H^UE#%-MT%?\!DV7PB;%P?*U AB@"F(SP']4U"*$@C,/.$
M0-$$G8Q<<S:E,R"NQ=0F5C,Y2O],L]>S:"K+FVOF9_7:U5SJYQQB\:4!8Z*S
M1)J$UY.8TB5\#M6UFDN=J6"89MH@;A$Q+*H ,N&9%%1.V\?1G02Q1T:Y<SJ^
M.X&$\PF4L=B3#G L[:J+!U^LCN?$8ALU4:8?\80$$.I.%6'$E 93H4*'@+DN
MS"&7:X:8.+0^9>86!3+-(\[9<ER07?94V(!=^)@K[@%E-#M(&?<DMI.##0H"
M$=(I<.0(11:4HM8 L,&(>"+-N3DV/P)%9PR=:;IHRXT07XQ%]9\AHK5@S$'Z
MXJFB)Q_]A4S;-W],8XE\6_M'"^&3Y-M>1:+V^T^X;3Y9BNR?"!26Q0EXTC)U
M7.;!(6@A.P)QLLV].)AY) J10:]X;A7\7$=/G4!.<U +QI\:C,T>RYX7Q2P0
M!&8I>0 IJL>I7F-#EWS55$[79/C3_!)+/V6"?5S24(  E/,:*6%RAPV<![<G
M:+,:4!IM0%!28STN=6"#$5LAC@5"Z&PX]-\!5?V!)^"7G2]R<[5P+:5M#Y=G
MT\I38FX>Q,K9;NF'.CU6G1Z05,J  T;Z6;Q4RC51[?).9#7U_+C_!!B5)LU+
MH81X$!?Z"&=<SI40C<#\TT2?(96H1WC>O"NR;*\E5,.CZ %6^*7OSH.'")&-
M063SMVP#<B5B6#2@;CY4(UMLS[.\E _!W(<]KC^)!GL)?>S(?L.#C*2KZJ+.
M%Z.L<CU8#(4%S.[C']CRH0"?6S.IT R0F& 2A4!8!CU]EV*GWA[[U8&)3Q&X
M<^/TS8$N@/R>?."W '#KJQ5WX+_8(=4=VP\:A)1Z<*TEF"R7<6#-'3P]ML_"
MH)-?@. Y2"Z;SAE?5U@2+GR/(N?9?F5J**)2FSV>.-&OA<*2?XVON3A/5,<6
MY[Y,XUJ3#6*HX.8K"A')!\#&<7\@XS2 A( 9Y-?U&%C_&8N^LKT_Z1:/*"YU
M-%' LO#7^MTK)UAO9^]FVN6@D\"5<726@TH%P'[*P7[CYMDZ'%['2>A'-?9O
M-WY:ZAL#FZGO++7O_X[-7+%&7X-VP=2FSB4N-ZF%,YC[5;$7&.KL_-,)NSP^
M_7A\R6Y./QV?="X9[.IWOLRO][-,36;#;+"3R^.3\\M;=EAG1[?'OW[L?'H1
M/AS<[OQ50[^@I/7]L?@"1N _I4.J3WERZ:].]FSNLG-;IMQA9]S$WVONYZ72
M,1OX&=]]^JXO?O[W_U!+ P04    "  LD25;&50;PZ,)  "M)   '@   &5A
M,#(U-C$W.3 Q97@Y.2TQ7VYE>'1T96-H+FAT;=U::V_;.!;];L#_@1L,.BG6
M5NQDFITD;C!YN-, :=JM,]OMIP4M43(;B51)*H[__9Y+2O(C:3 #M!@D05-'
M%'E?O/?<1S)Z>_WN\KC;&;T=GYSCD]'7Z/KB^G)\/-H)GWB[4[\>G;X__\PF
MUY\OQZ^W4JW<(1L.2L>N92$LNQ)S]E$77/7"0H]-A)'I%@[BZ(>_>NZ(%=QD
M4ATR;#UB3MRY/L]EA@4CLYG;.AZ='H_O9G(J'3LXB(:CG5,(_>'[L\M%2MPN
MCE^HJ2V/1CL7/YC/Z.+=[VSR\>SUEK@[..@/_S<8#*,O9;;%3BZO7V]ASP\7
MX;NKZJ\+A">Z,K$X#)3]"H[?@9*(9TKG.ENPMSI/I,K8A8JC[RO!C]$+2HG2
MB6(J3+<SV.VQW<'N*S;<.]P;L/'UWZ#!+W_]9AZ[ W:BE*Y4#'H_';!W,L^E
M5NRCR*1UPHB$G4LC8M?MO$]34%?9#XO$+Y5U,EULM4;XD3S.WHX_CZ^NQCWV
MZ3,=*UW$VMO=_OWR_>F878T_33Y=?!R_9/W^HW[,MJ].)N<G_SYD5_^]OG[)
MMMU,L!=Y\K721V>Z*+E:O##^Z66/.9WP!>.UU9-NQ\VX8X"Y&;=,J&!TJ9QF
MG"4BE4HZ>2L8SXP0!=ZSN70SII7 IEMAG38LQ3>Q+!%]H(+-*F&6YX+I%#_C
M+ YGW/GG_4%O,/#?]$3'6A$MB6B[G5@7!9P M..;'E.:E=RP6YY78DVUR8P;
M81O-V#:D*(WHIY5*H,*<&\.5LQ"3Y5)4Q,H(G;YD4)<O92V-C+U@/PVBX2M6
M"L,L$>YV<) SL_3$Q'LBM@9'C-CUJLZ!3FN*AP3!OP06E#'/<0WK)EL>#VKU
M )?6TIYN1]P)$\L-60';2V&CIQ\19,REHV1&0_O2Z%B(Q#;6JCTE. [,V5P%
M@PF8N"MQ/3 X-D]!J\3I.UF 6KX@;"D"MH1K<[@2RV-'8 -"S5E$@V9QKF%K
MO,!E\*FN'&LAF.V%$.TQ6TV_D#?4DEGNI$UK@A OAEJP@UEX:B1BK%4BZ;5]
M!I?UAY(4^S@05P9:T>'+RS,R)=F ;L0&NVB@0)GS.& 'S_#_,]"?7.C;R$!F
MF KZH>")CW%; 0&8QU0[$WE:'S;<^XMU<%)O'SR\T:9@D_X>VWXC8;LK';&]
MO;W^[OZ_]O9W7Q*PW$I=6?ATBO?PV.EB+38(>Q,1YYP$$Y H]OA=[_HCFD0K
MM^9WC^\ 02KS) II+8FTW6#L^*P%6"PO V&X[R-A%PD<@BB>=SN(-TMA5%E$
M1UGF]96# X_C(!W99&5;(FQL4&-CE82#,0O;9 5L*Q&'R=*J<P0P1;;7.Z0A
MV@@1/9/Z=;?#;[G,^33W,5SO^-FRN9A:"6C)=<P))I &9LZ5ASL[\_D\LB*.
M,GT;L7$.V8Q6,D;(EF2C6B"O)?NVDK1G5=$U@Q3(N1!=3QV72B0]-I\)I)=&
MTA[=#Q#"U='SK?BB3*U2_5L5WD<5UH%2=)@#W7#RGT.VO3N$H^S]LM?_%5_/
M(MHDY0+*AT;D@M)EHD%2:4=&PRY7.:HZNAWO+!1H5L ;ZF0,$)*Q=+P!9ZY8
MNV]:+:C$,,%]?(W@LP<BB2H8?_NVBF<@V 8-%09X_P7/-I%U$E&X4AG/NAV_
MV]/O;7 VH2B:ZRI/B$FE<CY/*W(JJ;TT:[" I:\5;)&B8/ +5$_4&BV% 8E6
MR&YG5:8( ;WJP ^[+BS*O<_5F>S;L$:U8R;(1,O@6XOL*6YFS>O7(_8^4/58
M54(OO/;D8US,2I"0M]\/7RRNQNO3]^Z6^C]0YK^1(D\.V0<DRB.0^%H)%.G@
MA!:@'J&,SB_^TX@1B/>=+K%EESC4*U/M4'X<LGU:FVH#OVG73I&-;]@P>@7A
MR3\3B- JMBIA[+N!EJ;G,GB B6_SEI8:[4#"!X2=&L%O^E.!&A<:E5[#5=+[
M#Y FI5;%6^\L-YFM&'"'+!B,]J1]X_3XQ%>@CX\QGD-'#$VT*;7QN1EH^FFA
M"](0^/".HTEBN[]2Q3$\Z#W>"U,)"@[MRQJ? /0R]P46VEJ@:E\H" 0D);05
MF>\IZIKGY (@EE-Y(C-@=XY:U@IGH[H0\OU# V*)R)&)C64G%Z!(J3QA$\XG
MB*S4S:DM08T#17OXO!6Y+MMR018U @=L!_I*E< 81H)CC(X5+2-JF=@W0@2#
M)U;R_@<>4S[P*$VZ*$HD"[0646.%4&OPW/HN"#R2##)18TD%C(H]TJ*A=N"#
M(C*77RN9>*/3GIC;F2\I<HAK>.;;J6X'9;L@.S&>A"8&,DI<6.$-*'AAHS6S
M3&$6$+#L5+I82]7T]LS/$T3(/PN& B^T1#1_(/:Y5EF?RD#?OHE8!N.@F<AR
M/:4BDR>Z]&OH$.>A?N5TXZ5VU%I#KAEIC$X#.<3Z<BGW1)Y!ID!KP J@IZ\!
M3>'5ZM$54T5T*ZU<JVC5G7,4!Q&N:>?I*P\HA/X(J:1_J?4-Q?NDZ9OL\X#
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MSA.=#?VMXYH=^G.C\/=']&=*_P=02P,$%     @ +)$E6Z,<%HXF P  X@L
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M='1E8V@N:'1M4$L! A0#%     @ +)$E6S13=%&TF0  <S0# !X
M     ( !2JP  &5A,#(U-C$W.3 Q97@Q,"TQ7VYE>'1T96-H+FAT;5!+ 0(4
M Q0    ( "R1)5NR!9(  $0  !9? 0 =              "  3I& 0!E83 R
M-38Q-SDP,65X-"TQ7VYE>'1T96-H+FAT;5!+ 0(4 Q0    ( "R1)5LD[/V^
MJA$  +U3   =              "  76* 0!E83 R-38Q-SDP,65X-2TQ7VYE
M>'1T96-H+FAT;5!+ 0(4 Q0    ( "R1)5NTNU:^YQ    58   =
M      "  5J< 0!E83 R-38Q-SDP,65X-2TR7VYE>'1T96-H+FAT;5!+ 0(4
M Q0    ( "R1)5L95!O#HPD  *TD   >              "  7RM 0!E83 R
M-38Q-SDP,65X.3DM,5]N97AT=&5C:"YH=&U02P$"% ,4    "  LD25;HQP6
MCB8#  #B"P  $0              @ %;MP$ ;GAT="TR,#(U,#DP,BYX<V10
M2P$"% ,4    "  LD25;?*-.P/T*  !_A@  %0              @ &PN@$
M;GAT="TR,#(U,#DP,E]L86(N>&UL4$L! A0#%     @ +)$E6TQ1?198!P
MU%<  !4              ( !X,4! &YX='0M,C R-3 Y,#)?<')E+GAM;%!+
4!08     "@ * - "  !KS0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea0256179-8k_nexttech_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nxtt-20250902.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001784970</identifier>
        </entity>
        <period>
            <startDate>2025-09-02</startDate>
            <endDate>2025-09-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-02" id="Fact000004">0001784970</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-02" id="Fact000010">2025-09-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-02" id="Fact000011">NEXT TECHNOLOGY HOLDING INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-02" id="Fact000012">WY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-02" id="Fact000013">001-41450</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-02" id="Fact000014">84-4948289</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-02" id="Fact000015">Room 519, 05/F Block T3</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-02" id="Fact000016">Qianhai Premier Finance Centre Unit 2</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-09-02" id="Fact000017">Guiwan Area, Nanshan District</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-02" id="Fact000018">Shenzhen</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-09-02" id="Fact000019">CN</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-02" id="Fact000020">518000</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-02" id="Fact000021">+44</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-02" id="Fact000022">7421477289</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-02" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-02" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-02" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-02" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-02" id="Fact000027">Common Stock, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-02" id="Fact000028">NXTT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-02" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-02" id="Fact000030">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-02" id="Fact000031">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
